| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1C1 ABCA4 ATRX RTEL1 ABCA13 CHD3 TRIP13 ABCA8 IFIH1 UBA7 MDN1 ATP11B MYO3B SHOC1 ATP11C HFM1 KIF2A CHD6 DNAH8 KIF22 RAD51C DNAH3 DDX31 DDX52 SMARCAL1 DNAH2 RNF213 ABCC9 NLRP1 ATP10D DNAH1 ATP12A ATP2A1 ATP2A2 AQR DNAH11 | 7.31e-13 | 614 | 286 | 36 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA4 ATRX RTEL1 ABCA13 CHD3 TRIP13 ABCA8 IFIH1 MDN1 ATP11B SHOC1 ATP11C HFM1 KIF2A CHD6 DNAH8 KIF22 DNAH3 DDX31 DDX52 DNAH2 RNF213 ABCC9 NLRP1 ATP10D ATP12A ATP2A1 ATP2A2 AQR DNAH11 | 1.70e-12 | 441 | 286 | 30 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA4 ATRX RTEL1 ABCA13 CHD3 TRIP13 ABCA8 IFIH1 MDN1 ATP11B SHOC1 ATP11C HFM1 KIF2A CHD6 DNAH8 RAB26 KIF22 DNAH3 DDX31 DDX52 DNAH2 RNF213 ABCC9 NLRP1 ARHGAP35 ATP10D GTPBP2 ATP12A ATP2A1 ATP2A2 AQR DNAH11 | 2.44e-08 | 775 | 286 | 33 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA4 ATRX RTEL1 ABCA13 CHD3 TRIP13 ABCA8 IFIH1 MDN1 ATP11B SHOC1 ATP11C HFM1 KIF2A CHD6 DNAH8 RAB26 KIF22 DNAH3 DDX31 DDX52 DNAH2 RNF213 ABCC9 NLRP1 ARHGAP35 ATP10D GTPBP2 ATP12A ATP2A1 ATP2A2 AQR DNAH11 | 1.56e-07 | 839 | 286 | 33 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA4 ATRX RTEL1 ABCA13 CHD3 TRIP13 ABCA8 IFIH1 MDN1 ATP11B SHOC1 ATP11C HFM1 KIF2A CHD6 DNAH8 RAB26 KIF22 DNAH3 DDX31 DDX52 DNAH2 RNF213 ABCC9 NLRP1 ARHGAP35 ATP10D GTPBP2 ATP12A ATP2A1 ATP2A2 AQR DNAH11 | 1.61e-07 | 840 | 286 | 33 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA4 ATRX RTEL1 ABCA13 CHD3 TRIP13 ABCA8 IFIH1 MDN1 ATP11B SHOC1 ATP11C HFM1 KIF2A CHD6 DNAH8 RAB26 KIF22 DNAH3 DDX31 DDX52 DNAH2 RNF213 ABCC9 NLRP1 ARHGAP35 ATP10D GTPBP2 ATP12A ATP2A1 ATP2A2 AQR DNAH11 | 1.61e-07 | 840 | 286 | 33 | GO:0016818 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.28e-06 | 18 | 286 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.37e-05 | 28 | 286 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ATRX RTEL1 CHD3 IFIH1 FARSA HFM1 CHD6 EXOG TRDMT1 DNMT3B RAD51C DDX31 DDX52 NTHL1 SMARCAL1 POLR2A POLRMT EXOSC1 DCLRE1B TOE1 LIG3 HARS1 AQR | 6.00e-05 | 645 | 286 | 23 | GO:0140640 |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.37e-05 | 70 | 286 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | flippase activity | 8.47e-05 | 17 | 286 | 4 | GO:0140327 | |
| GeneOntologyMolecularFunction | helicase activity | 9.64e-05 | 158 | 286 | 10 | GO:0004386 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 9.75e-05 | 7 | 286 | 3 | GO:0090555 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.74e-04 | 37 | 286 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.75e-04 | 109 | 286 | 8 | GO:0042626 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.01e-04 | 118 | 286 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ATRX RTEL1 CHD3 HFM1 CHD6 EXOG DNMT3B RAD51C NTHL1 SMARCAL1 DCLRE1B LIG3 | 4.20e-04 | 262 | 286 | 12 | GO:0140097 |
| GeneOntologyMolecularFunction | linoleate 13S-lipoxygenase activity | 6.08e-04 | 3 | 286 | 2 | GO:0016165 | |
| GeneOntologyMolecularFunction | arachidonate 15-lipoxygenase activity | 6.08e-04 | 3 | 286 | 2 | GO:0050473 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 6.43e-04 | 28 | 286 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 9.41e-04 | 14 | 286 | 3 | GO:0140333 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | KNTC1 MAN1A1 ATRX AUP1 VPS13C ENTR1 OBSCN SRP68 TSC2 DNAAF11 CEP350 MAGI2 PMPCA MIPEP VPS13A KICS2 CPLANE1 TASOR HEATR3 GOLGB1 TOR1AIP2 SYNE1 NUMA1 RDX CEP192 VPS54 STAM CUBN IPO4 DDRGK1 TOR1AIP1 IL6 TP53BP1 SORL1 DNAH11 | 2.94e-06 | 1091 | 284 | 35 | GO:0033365 |
| GeneOntologyCellularComponent | sarcomere | CAB39 SPTBN1 OBSCN KLHL41 RYR3 ANKRD2 CACNA1S FLNB FLNC SYNE1 KLHL40 ABCC9 MYOM2 ATP2A1 AHNAK2 | 1.90e-06 | 249 | 286 | 15 | GO:0030017 |
| GeneOntologyCellularComponent | myofibril | CAB39 SPTBN1 OBSCN KLHL41 RYR3 ANKRD2 CACNA1S FLNB FLNC SYNE1 KLHL40 ABCC9 MYOM2 ATP2A1 AHNAK2 | 5.87e-06 | 273 | 286 | 15 | GO:0030016 |
| GeneOntologyCellularComponent | contractile muscle fiber | CAB39 SPTBN1 OBSCN KLHL41 RYR3 ANKRD2 CACNA1S FLNB FLNC SYNE1 KLHL40 ABCC9 MYOM2 ATP2A1 AHNAK2 | 1.21e-05 | 290 | 286 | 15 | GO:0043292 |
| GeneOntologyCellularComponent | A band | 7.47e-05 | 52 | 286 | 6 | GO:0031672 | |
| GeneOntologyCellularComponent | I band | CAB39 OBSCN RYR3 ANKRD2 CACNA1S FLNB FLNC KLHL40 ATP2A1 AHNAK2 | 1.00e-04 | 166 | 286 | 10 | GO:0031674 |
| GeneOntologyCellularComponent | 9+2 motile cilium | SPEF2 CFAP65 SLC26A8 VPS13A KIF2A DNAH8 DNAH3 DNAH2 DNAH1 USP26 TMEM232 DNAH11 | 1.15e-04 | 238 | 286 | 12 | GO:0097729 |
| GeneOntologyCellularComponent | inner dynein arm | 2.83e-04 | 10 | 286 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.46e-04 | 25 | 286 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | motile cilium | SPEF2 DNAAF11 CFAP65 SLC26A8 VPS13A KIF2A DNAH8 DNAH3 PRAMEF22 DNAH2 DNAH1 USP26 TMEM232 DNAH11 | 4.10e-04 | 355 | 286 | 14 | GO:0031514 |
| GeneOntologyCellularComponent | cyclin E1-CDK2 complex | 5.55e-04 | 3 | 286 | 2 | GO:0097134 | |
| GeneOntologyCellularComponent | cilium | ABCA4 CDHR1 SPEF2 ENTR1 DNAAF11 ADGRV1 CFAP65 MAGI2 SLC26A8 MYO3B VPS13A PCDH15 KIF2A CPLANE1 DNAH8 MACIR DNAH3 PRAMEF22 DNAH2 ARHGAP35 DNAH1 DNAAF2 USP26 TMEM232 DNAH11 | 6.42e-04 | 898 | 286 | 25 | GO:0005929 |
| GeneOntologyCellularComponent | sperm flagellum | SPEF2 CFAP65 SLC26A8 VPS13A KIF2A DNAH8 DNAH2 DNAH1 USP26 TMEM232 | 7.63e-04 | 214 | 286 | 10 | GO:0036126 |
| GeneOntologyCellularComponent | M band | 8.07e-04 | 31 | 286 | 4 | GO:0031430 | |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 8.25e-04 | 14 | 286 | 3 | GO:1990531 | |
| GeneOntologyCellularComponent | dynein complex | 8.46e-04 | 54 | 286 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | sarcoplasm | 9.87e-04 | 114 | 286 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | dense core granule | 1.00e-03 | 56 | 286 | 5 | GO:0031045 | |
| GeneOntologyCellularComponent | lipid droplet | 1.09e-03 | 116 | 286 | 7 | GO:0005811 | |
| GeneOntologyCellularComponent | sarcolemma | 1.26e-03 | 190 | 286 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 1.43e-03 | 36 | 286 | 4 | GO:0098992 | |
| GeneOntologyCellularComponent | secretory granule | CAB39 SERPINA3 CAND1 GHDC ABCA13 VPS13C CYP51A1 NCF2 STK11IP CFAP65 SERPINI1 ADRB2 ATP11B SCG2 VPS13A RAB26 MGAM STXBP5L PRAMEF22 ABCC9 REG1A REG1B STK31 GTPBP2 PADI2 ICA1L | 1.64e-03 | 1014 | 286 | 26 | GO:0030141 |
| GeneOntologyCellularComponent | supramolecular fiber | KNTC1 CAB39 EPPK1 SPTBN1 OBSCN KLHL41 RYR3 NDRG1 ANKRD2 KIF2A DNAH8 KIF22 CACNA1S FLNB FLNC DNAH3 SYNE1 KLHL40 CARMIL1 NUMA1 DNAH2 ABCC9 DNAH1 CLIP4 TMEM232 MYOM2 ATP2A1 AHNAK2 DNAH11 | 1.67e-03 | 1179 | 286 | 29 | GO:0099512 |
| GeneOntologyCellularComponent | perinucleolar compartment | 1.82e-03 | 5 | 286 | 2 | GO:0097356 | |
| GeneOntologyCellularComponent | supramolecular polymer | KNTC1 CAB39 EPPK1 SPTBN1 OBSCN KLHL41 RYR3 NDRG1 ANKRD2 KIF2A DNAH8 KIF22 CACNA1S FLNB FLNC DNAH3 SYNE1 KLHL40 CARMIL1 NUMA1 DNAH2 ABCC9 DNAH1 CLIP4 TMEM232 MYOM2 ATP2A1 AHNAK2 DNAH11 | 1.84e-03 | 1187 | 286 | 29 | GO:0099081 |
| Domain | ATPase_dyneun-rel_AAA | 3.05e-08 | 14 | 282 | 6 | IPR011704 | |
| Domain | AAA_5 | 3.05e-08 | 14 | 282 | 6 | PF07728 | |
| Domain | ARM-type_fold | MON2 CAB39 GPRASP1 CAND1 INTS1 TSC2 CUL7 TEX10 LYST RYR3 DOCK5 PIK3CA NCAPD2 HEATR5B HEATR3 MROH2A IPO4 ECPAS VIRMA CNOT9 | 2.42e-07 | 339 | 282 | 20 | IPR016024 |
| Domain | P-loop_NTPase | ABCA4 ATRX RTEL1 ABCA13 SPEF2 CHD3 SLFN5 TRIP13 ABCA8 MAGI2 IFIH1 MDN1 MYO3B HFM1 KIF2A CHD6 DNAH8 RAB26 KIF22 RAD51C DNAH3 DDX31 DDX52 SMARCAL1 DNAH2 RNF213 ABCC9 NLRP1 ARHGAP35 DNAH1 GTPBP2 AQR DNAH11 | 6.39e-07 | 848 | 282 | 33 | IPR027417 |
| Domain | MT | 1.36e-06 | 14 | 282 | 5 | PF12777 | |
| Domain | AAA_8 | 1.36e-06 | 14 | 282 | 5 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.36e-06 | 14 | 282 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.36e-06 | 14 | 282 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.36e-06 | 14 | 282 | 5 | IPR013602 | |
| Domain | DHC_N2 | 1.36e-06 | 14 | 282 | 5 | PF08393 | |
| Domain | AAA+_ATPase | ABCA4 ABCA13 TRIP13 ABCA8 MDN1 DNAH8 RAD51C DNAH3 DNAH2 RNF213 ABCC9 DNAH11 | 1.96e-06 | 144 | 282 | 12 | IPR003593 |
| Domain | AAA | ABCA4 ABCA13 TRIP13 ABCA8 MDN1 DNAH8 RAD51C DNAH3 DNAH2 RNF213 ABCC9 DNAH11 | 1.96e-06 | 144 | 282 | 12 | SM00382 |
| Domain | DHC_fam | 2.01e-06 | 15 | 282 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 2.01e-06 | 15 | 282 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.01e-06 | 15 | 282 | 5 | IPR004273 | |
| Domain | - | ABCA4 ATRX RTEL1 ABCA13 SPEF2 CHD3 SLFN5 TRIP13 ABCA8 IFIH1 MDN1 HFM1 CHD6 DNAH8 RAB26 RAD51C DNAH3 DDX31 DDX52 SMARCAL1 DNAH2 RNF213 ABCC9 NLRP1 ARHGAP35 DNAH1 GTPBP2 AQR DNAH11 | 3.27e-06 | 746 | 282 | 29 | 3.40.50.300 |
| Domain | - | 7.32e-06 | 32 | 282 | 6 | 3.40.1110.10 | |
| Domain | - | 7.32e-06 | 32 | 282 | 6 | 2.70.150.10 | |
| Domain | ATPase_P-typ_cyto_domN | 1.26e-05 | 35 | 282 | 6 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 1.50e-05 | 36 | 282 | 6 | IPR018303 | |
| Domain | P_typ_ATPase | 1.50e-05 | 36 | 282 | 6 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.50e-05 | 36 | 282 | 6 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.76e-05 | 37 | 282 | 6 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.76e-05 | 37 | 282 | 6 | PF00122 | |
| Domain | - | MON2 CAB39 GPRASP1 CAND1 TSC2 CUL7 TEX10 NCAPD2 HEATR5B HEATR3 IPO4 ECPAS CNOT9 | 3.46e-05 | 222 | 282 | 13 | 1.25.10.10 |
| Domain | ARM-like | MON2 CAB39 GPRASP1 CAND1 TSC2 CUL7 TEX10 NCAPD2 HEATR5B HEATR3 MROH2A IPO4 ECPAS CNOT9 | 6.58e-05 | 270 | 282 | 14 | IPR011989 |
| Domain | HEAT | 8.09e-05 | 48 | 282 | 6 | PF02985 | |
| Domain | HEAT_REPEAT | 8.83e-05 | 70 | 282 | 7 | PS50077 | |
| Domain | DHC_N1 | 1.80e-04 | 8 | 282 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.80e-04 | 8 | 282 | 3 | IPR013594 | |
| Domain | Helicase_C | 2.19e-04 | 107 | 282 | 8 | PF00271 | |
| Domain | HELICc | 2.19e-04 | 107 | 282 | 8 | SM00490 | |
| Domain | Gonadal | 2.27e-04 | 2 | 282 | 2 | IPR010849 | |
| Domain | DGCR6 | 2.27e-04 | 2 | 282 | 2 | PF07324 | |
| Domain | Cyclin_E | 2.27e-04 | 2 | 282 | 2 | IPR028858 | |
| Domain | Lamina-ass_polypeptide_CLAP1C | 2.27e-04 | 2 | 282 | 2 | IPR008662 | |
| Domain | LAP1C | 2.27e-04 | 2 | 282 | 2 | PF05609 | |
| Domain | Helicase_C | 2.34e-04 | 108 | 282 | 8 | IPR001650 | |
| Domain | HEAT | 2.35e-04 | 58 | 282 | 6 | IPR000357 | |
| Domain | DEXDc | 2.49e-04 | 109 | 282 | 8 | SM00487 | |
| Domain | HELICASE_CTER | 2.49e-04 | 109 | 282 | 8 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.49e-04 | 109 | 282 | 8 | PS51192 | |
| Domain | Helicase_ATP-bd | 2.65e-04 | 110 | 282 | 8 | IPR014001 | |
| Domain | ACTININ_2 | 3.59e-04 | 23 | 282 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.59e-04 | 23 | 282 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.59e-04 | 23 | 282 | 4 | IPR001589 | |
| Domain | Hydrolase_3 | 3.78e-04 | 10 | 282 | 3 | PF08282 | |
| Domain | VPS13_N2 | 6.75e-04 | 3 | 282 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 6.75e-04 | 3 | 282 | 2 | IPR031642 | |
| Domain | P-type_ATPase_IIA | 6.75e-04 | 3 | 282 | 2 | IPR005782 | |
| Domain | VPS13 | 6.75e-04 | 3 | 282 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 6.75e-04 | 3 | 282 | 2 | PF16910 | |
| Domain | VPS13 | 6.75e-04 | 3 | 282 | 2 | PF16908 | |
| Domain | ABC_A | 6.77e-04 | 12 | 282 | 3 | IPR026082 | |
| Domain | CH | 8.20e-04 | 73 | 282 | 6 | PS50021 | |
| Domain | CH-domain | 9.46e-04 | 75 | 282 | 6 | IPR001715 | |
| Domain | P_typ_ATPase_c | 1.10e-03 | 14 | 282 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.10e-03 | 14 | 282 | 3 | IPR032631 | |
| Domain | PhoLip_ATPase_C | 1.10e-03 | 14 | 282 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.10e-03 | 14 | 282 | 3 | PF16209 | |
| Domain | P-type_ATPase_IV | 1.10e-03 | 14 | 282 | 3 | IPR006539 | |
| Domain | HAD-like_dom | 1.24e-03 | 79 | 282 | 6 | IPR023214 | |
| Domain | SNF2_N | 1.31e-03 | 32 | 282 | 4 | PF00176 | |
| Domain | SNF2_N | 1.31e-03 | 32 | 282 | 4 | IPR000330 | |
| Domain | DNA_methylase | 1.34e-03 | 4 | 282 | 2 | PF00145 | |
| Domain | ADD | 1.34e-03 | 4 | 282 | 2 | IPR025766 | |
| Domain | C5_DNA_meth_AS | 1.34e-03 | 4 | 282 | 2 | IPR018117 | |
| Domain | VPS13_C | 1.34e-03 | 4 | 282 | 2 | IPR031645 | |
| Domain | SHR-BD | 1.34e-03 | 4 | 282 | 2 | IPR009543 | |
| Domain | C5_MTASE_1 | 1.34e-03 | 4 | 282 | 2 | PS00094 | |
| Domain | C5_MTASE_2 | 1.34e-03 | 4 | 282 | 2 | PS00095 | |
| Domain | Lipase_GDXG_HIS_AS | 1.34e-03 | 4 | 282 | 2 | IPR002168 | |
| Domain | SAM_MT_C5 | 1.34e-03 | 4 | 282 | 2 | PS51679 | |
| Domain | Lipase_GDXG_put_SER_AS | 1.34e-03 | 4 | 282 | 2 | IPR033140 | |
| Domain | C5_MeTfrase | 1.34e-03 | 4 | 282 | 2 | IPR001525 | |
| Domain | VPS13_C | 1.34e-03 | 4 | 282 | 2 | PF16909 | |
| Domain | ADD | 1.34e-03 | 4 | 282 | 2 | PS51533 | |
| Domain | SHR-BD | 1.34e-03 | 4 | 282 | 2 | PF06650 | |
| Domain | ATPase_P-typ_TM_dom | 1.65e-03 | 16 | 282 | 3 | IPR023298 | |
| Domain | - | 1.65e-03 | 16 | 282 | 3 | 1.20.1110.10 | |
| Domain | Cation_ATPase_C | 1.98e-03 | 17 | 282 | 3 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.98e-03 | 17 | 282 | 3 | IPR006068 | |
| Domain | Autophagy-rel_C | 2.20e-03 | 5 | 282 | 2 | IPR015412 | |
| Domain | ATG_C | 2.20e-03 | 5 | 282 | 2 | PF09333 | |
| Domain | Cation_ATPase_N | 2.35e-03 | 18 | 282 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 2.35e-03 | 18 | 282 | 3 | SM00831 | |
| Pubmed | KNTC1 FAM114A1 ATRX SPEF2 SPTBN1 TMEM135 CHD3 ZNF318 TEX10 TRIP13 LYST ZEB2 MDN1 NRXN1 PMPCA SACS ZBTB21 VPS13A NCAPD2 ATP11C CHD6 SIPA1L2 TASOR DNAH8 GOLGB1 DNMT3B FLNB FLNC DDX52 SYNE1 NUMA1 DNAH2 RDX STK31 ZNF675 SF3B3 DDRGK1 MPHOSPH8 MYOM2 MAPK6 ATP12A ATP2A1 ATP2A2 | 3.21e-13 | 1442 | 287 | 43 | 35575683 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CAND1 MAN1A1 GHDC AUP1 CYP51A1 SRP68 TSC2 TEX10 TRIP13 PGM3 FARSA FOXRED2 NCAPD2 HEATR5B IQGAP3 HEATR3 NPC1 TOR1AIP2 EXOC6 DDX52 AHCTF1 DNAH2 TTC27 IPO4 ECPAS FANCI MTR CSTF3 DDRGK1 ATP2A2 TOR1AIP1 SLC33A1 | 1.68e-11 | 942 | 287 | 32 | 31073040 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ZFYVE27 VPS13C INTS1 OBSCN SRP68 TSC2 SLFN5 ITGAE DOCK5 MDN1 MYO3B VPS13A CHD6 HEATR3 CA12 FLNB DNAH3 FAT4 POLR2A PCDHB12 DNAH2 MUC19 RNF213 ECPAS ZNF675 LIG3 RDH16 RBM43 | 2.54e-11 | 736 | 287 | 28 | 29676528 |
| Pubmed | EPPK1 SPTBN1 INTS1 SRP68 ZNF318 CUL7 TEX10 TTF1 MDN1 NCAPD2 FLNB FLNC CAD DDX31 DDX52 AHCTF1 POLR2A NUMA1 POLRMT IPO4 ECPAS VIRMA FANCI ATP2A2 AQR TP53BP1 | 5.06e-11 | 653 | 287 | 26 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 CAND1 ATRX AUP1 VPS13C SPTBN1 SRP68 TRIP13 FARSA MDN1 ADSL PMPCA NCAPD2 KIF2A IQGAP3 FLNB CAD DDX52 SYNE1 POLR2A NUMA1 POLRMT RDX BIRC3 IPO4 ECPAS TOE1 LIG3 METTL13 SF3B3 FANCI MTR CSTF3 MPHOSPH8 HARS1 ATP2A2 TOR1AIP1 AQR | 2.22e-10 | 1425 | 287 | 38 | 30948266 |
| Pubmed | 7.66e-10 | 7 | 287 | 5 | 9256245 | ||
| Pubmed | ATP6V1C1 CAND1 ATRX AUP1 INTS1 SRP68 ZNF318 TEX10 TTF1 FARSA MDN1 NCAPD2 KIF2A CHD6 HEATR5B TASOR IQGAP3 GOLGB1 KIF22 SAMD1 CAD DDX31 DDX52 SYNE1 NTHL1 AHCTF1 POLR2A POLRMT EXOSC1 IPO4 VIRMA TOE1 CNOT9 CSTF3 DDRGK1 MPHOSPH8 ATP2A2 AQR | 8.80e-10 | 1497 | 287 | 38 | 31527615 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | MON2 ATP6V1C1 TSC2 CUL7 ATP11B PMPCA ATP11C SLC25A17 FLNC CAD DDX52 POLR2A NUMA1 IPO4 GTPBP2 FANCI MTR | 1.28e-09 | 313 | 287 | 17 | 38270169 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPPK1 CAND1 INTS1 CHD3 ZNF318 CUL7 TEX10 TRIP13 CEP350 MDN1 SACS ZBTB21 KIF2A HEATR5B GOLGB1 KIF22 FLNB FLNC CAD DDX52 SYNE1 POLR2A NUMA1 LIG3 SF3B3 CSTF3 ATP2A2 TOR1AIP1 AQR | 9.70e-09 | 1024 | 287 | 29 | 24711643 |
| Pubmed | TPTE CHD3 IQGAP3 NPC1 CAD POLR2A NUMA1 VIRMA PDHX SF3B3 ATP2A1 ATP2A2 AQR | 1.58e-08 | 202 | 287 | 13 | 24639526 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPPK1 ATRX SPTBN1 SRP68 CHD3 TRIP13 MDN1 NCAPD2 KIF2A MPI FLNB POLR2A NUMA1 RNF213 TP53BP1 AHNAK2 | 2.13e-08 | 332 | 287 | 16 | 32786267 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CAND1 ATRX RTEL1 VPS13C OBSCN CHD3 ADGRV1 ACVR2B CDK14 TTF1 TRIP13 DOCK5 NDRG1 ATP11B PTPRG TBC1D1 CHD6 DENND5A GOLGB1 NSMAF FLNB STXBP5L CARMIL1 PRR5 RNF213 CEP192 VPS54 ARHGAP35 ECPAS DNAH1 USP40 CSTF3 MAPK6 MBD5 ICA1L | 2.96e-08 | 1489 | 287 | 35 | 28611215 |
| Pubmed | MON2 CAND1 AUP1 ENTR1 TSC2 STK11IP TRIP13 MDN1 PMPCA VPS13A NCAPD2 KIF2A SIPA1L2 IQGAP3 TOR1AIP2 EXOC6 TTC27 IPO4 METTL13 FANCI MTR | 4.25e-08 | 606 | 287 | 21 | 36538041 | |
| Pubmed | 6.96e-08 | 14 | 287 | 5 | 9373155 | ||
| Pubmed | 1.21e-07 | 29 | 287 | 6 | 15071553 | ||
| Pubmed | MON2 ENTR1 CHD3 ZNF318 CUL7 TRIP13 ABCA8 HMCN2 ANKRD2 ZBTB21 SIPA1L2 WWC1 WDR72 TOR1AIP2 SAMD1 DDX52 AHCTF1 POLR2A POLRMT TTC27 RNF213 PDHX METTL13 GTPBP2 SF3B3 MTR PADI2 SORL1 | 2.16e-07 | 1116 | 287 | 28 | 31753913 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CAND1 SRP68 CHD3 CUL7 TEX10 TTF1 FARSA MDN1 KIF2A TASOR IQGAP3 KIF22 EXOC6 SAMD1 DDX31 DDX52 NUMA1 POLRMT VIRMA PDHX LIG3 AQR | 4.34e-07 | 759 | 287 | 22 | 35915203 |
| Pubmed | ABCA4 AUP1 SRP68 CEP350 MDN1 VPS13A HFM1 CHD6 UTY TOR1AIP2 EXOC6 FAT4 SMARCAL1 DNAH2 STK31 VIRMA LIG3 NCOA1 AHNAK2 DNAH11 | 4.40e-07 | 638 | 287 | 20 | 31182584 | |
| Pubmed | AUP1 SPTBN1 SRP68 FARSA NDRG1 NCAPD2 GOLGB1 FLNB CAD CARMIL1 AHCTF1 NUMA1 RDX STAM ECPAS SF3B3 MAP4K5 FANCI SH3D19 MAP3K21 ATP2A2 | 5.53e-07 | 708 | 287 | 21 | 39231216 | |
| Pubmed | Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells. | 5.56e-07 | 3 | 287 | 3 | 20056108 | |
| Pubmed | TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes. | 5.56e-07 | 3 | 287 | 3 | 33087848 | |
| Pubmed | ANKRD31 RTEL1 VPS13C ADGRV1 CACNA1S FRAS1 SYNE1 FANCI MAP3K21 DNAH11 | 5.99e-07 | 152 | 287 | 10 | 34299191 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 EPPK1 INTS1 OBSCN TSC2 STK11IP LYST MDN1 NCAPD2 DENND5A SNX11 SIPA1L2 IQGAP3 GAREM1 NPC1 FLNC FRAS1 POLR2A AOC2 POLRMT CEP192 ARHGAP35 CCNE1 FANCI USP40 MBD5 AHNAK2 | 6.00e-07 | 1105 | 287 | 27 | 35748872 |
| Pubmed | INTS1 SRP68 CHD3 SLFN5 CUL7 TEX10 ZEB2 MDN1 NCAPD2 CHD6 IQGAP3 IPO4 LSM8 | 7.54e-07 | 282 | 287 | 13 | 23667531 | |
| Pubmed | ATRX AUP1 SPTBN1 ENTR1 CYP51A1 HSPA12A MDN1 PMPCA SACS VPS13A SIPA1L2 MACIR GOLGB1 TOR1AIP2 FRAS1 CAD DDX31 SYNE1 AHCTF1 POLRMT CEP192 IPO4 PDHX SF3B3 MAP4K5 MTR DDRGK1 ATP2A2 TOR1AIP1 SLC33A1 AQR TP53BP1 | 8.44e-07 | 1487 | 287 | 32 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAND1 AUP1 SPTBN1 SRP68 TEX10 TRIP13 MDN1 ADSL NCAPD2 KIF2A FLNB FLNC CAD DDX52 AHCTF1 POLR2A NUMA1 POLRMT TTC27 IPO4 TOE1 LIG3 METTL13 SF3B3 MAP4K5 FANCI ATP2A2 AQR TP53BP1 AHNAK2 | 1.04e-06 | 1353 | 287 | 30 | 29467282 |
| Pubmed | GPRASP1 DGCR6 CAND1 ATRX SPTBN1 TSC2 ZEB2 RYR3 CEP350 MAGI2 UBA7 NDRG1 SACS SCG2 CHD6 NPC1 FLNB SYNE1 TTC27 RDX VPS54 STAM CLIP4 SH3D19 LRRCC1 RAB11FIP4 HARS1 ATP2A2 PADI2 | 1.12e-06 | 1285 | 287 | 29 | 35914814 | |
| Pubmed | MON2 ZFYVE27 AUP1 VPS13C CYP51A1 TSC2 STK11IP LYST VPS13A SNX11 HEATR5B GOLGB1 NPC1 TOR1AIP2 DDRGK1 TOR1AIP1 SLC33A1 | 1.22e-06 | 504 | 287 | 17 | 34432599 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KNTC1 CAB39 EPPK1 VPS13C SPTBN1 OBSCN ABCA8 CPLANE1 IQGAP3 GOLGB1 FLNB FLNC CAD REXO5 PRAMEF22 SPATA24 TTC27 ATP2A2 | 1.30e-06 | 564 | 287 | 18 | 21565611 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CAND1 SPTBN1 CYP51A1 INTS1 SRP68 TEX10 FARSA NRXN1 SACS PCDH15 KIF2A CHD6 SIPA1L2 DNMT3B FLNC CAD SYNE1 POLR2A ARHGAP35 TOE1 LIG3 SF3B3 CSTF3 MPHOSPH8 ATP2A2 AQR | 1.33e-06 | 1082 | 287 | 26 | 38697112 |
| Pubmed | FAM114A1 AUP1 VPS13C SPTBN1 CYP51A1 SRP68 NDRG1 VPS13A TOR1AIP2 FLNB FLNC AHCTF1 NUMA1 RDX DDRGK1 TOR1AIP1 SLC33A1 AHNAK2 | 1.44e-06 | 568 | 287 | 18 | 37774976 | |
| Pubmed | GPRASP1 CAND1 SPTBN1 TSC2 ZNF318 TEX10 JAKMIP2 ZEB2 MAGI2 FARSA MDN1 NRXN1 ZBTB21 KIF2A EXOG GOLGB1 CAD SYNE1 NUMA1 RDX IPO4 VIRMA SH3D19 TP53BP1 | 1.85e-06 | 963 | 287 | 24 | 28671696 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | EPPK1 CAND1 ATRX SPTBN1 INTS1 SRP68 CHD3 TRIP13 DOCK5 HSPA12A MDN1 NCAPD2 GOLGB1 METTL13 SF3B3 FANCI CSTF3 AQR | 2.03e-06 | 582 | 287 | 18 | 20467437 |
| Pubmed | 2.21e-06 | 4 | 287 | 3 | 20876350 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 KNTC1 ATRX ENTR1 ZNF318 CUL7 FARSA SIPA1L2 GOLGB1 CAD DDX31 EXOSC1 CEP192 IPO4 SF3B3 MTR TP53BP1 SORL1 | 2.34e-06 | 588 | 287 | 18 | 38580884 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | EPPK1 SPTBN1 MDN1 FLNB FRAS1 CAD DDX52 POLR2A NUMA1 RDX SF3B3 | 2.36e-06 | 219 | 287 | 11 | 31353912 |
| Pubmed | MON2 TPTE SPTBN1 ENTR1 CUL7 TEX10 CEP350 HSPA12A PTPRG PMPCA VPS13A KIF22 TOR1AIP2 CAD DDX31 POLR2A TTC27 RNF213 CEP192 STAM FAM171B FANCI CSTF3 HARS1 ATP2A2 | 2.48e-06 | 1049 | 287 | 25 | 27880917 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TMEM135 INTS1 TTF1 STK11IP DOCK5 MDN1 NDRG1 PMPCA MIPEP VPS13A ATP11C EXOG BICC1 GOLGB1 WDR72 CA12 TOR1AIP2 DOLK TTC27 RNF213 PDHX FANCI GLCE ATP12A SLC33A1 | 3.03e-06 | 1061 | 287 | 25 | 33845483 |
| Pubmed | 3.26e-06 | 76 | 287 | 7 | 27542412 | ||
| Pubmed | 3.37e-06 | 144 | 287 | 9 | 30585266 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SPTBN1 TSC2 CDK14 LYST CEP350 MDN1 NDRG1 TBC1D1 ZBTB21 KIF2A SIPA1L2 MACIR BICC1 GOLGB1 CARMIL1 PRR5 CEP192 VIRMA SH3D19 MAP3K21 AQR AHNAK2 | 3.40e-06 | 861 | 287 | 22 | 36931259 |
| Pubmed | MON2 KNTC1 CAND1 AUP1 SPTBN1 TSC2 TRIP13 PGM3 FARSA MDN1 NCAPD2 HEATR3 FLNB CAD NUMA1 POLRMT EXOSC1 TTC27 RNF213 IPO4 ECPAS CCNE1 LIG3 SF3B3 CNOT9 CCNE2 FANCI COMMD7 ATP2A2 AHNAK2 | 3.63e-06 | 1440 | 287 | 30 | 30833792 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CAND1 ATRX SRP68 CHD3 ZNF318 NDRG1 ZBTB21 SIPA1L2 TASOR GOLGB1 CARMIL1 AHCTF1 POLR2A NUMA1 RDX STAM ARHGAP35 LIG3 SH3D19 DDRGK1 TOR1AIP1 TP53BP1 AHNAK2 | 3.73e-06 | 934 | 287 | 23 | 33916271 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPPK1 CAND1 SPTBN1 MDN1 IQGAP3 FLNB FLNC CAD SYNE1 POLR2A NUMA1 MUC19 IPO4 ECPAS EPG5 DNAH1 SF3B3 HARS1 ATP2A1 ATP2A2 AHNAK2 | 4.32e-06 | 807 | 287 | 21 | 30575818 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | INTS1 TSC2 CHD3 NCAPD2 SAMD1 SMARCAL1 POLR2A RNF213 ECPAS LIG3 FANCI AQR TP53BP1 | 6.08e-06 | 341 | 287 | 13 | 32971831 |
| Pubmed | MON2 CAB39 CAND1 ATRX AUP1 INTS1 TSC2 CDK14 TRIP13 PGM3 PIK3CA KICS2 HEATR3 SAMD1 CAD SMARCAL1 EXOSC1 VPS54 DCLRE1B VIRMA GTPBP2 SF3B3 GLCE MYLIP NCOA1 MPHOSPH8 MAPK6 SLC33A1 | 6.16e-06 | 1327 | 287 | 28 | 32694731 | |
| Pubmed | 6.20e-06 | 32 | 287 | 5 | 20301301 | ||
| Pubmed | 6.21e-06 | 197 | 287 | 10 | 31620119 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MON2 CAND1 AUP1 CYP51A1 INTS1 TSC2 TRIP13 PGM3 FARSA FOXRED2 MDN1 ADSL PMPCA IQGAP3 RAD51C TOR1AIP2 SAMD1 CAD POLR2A TTC27 IPO4 METTL13 SF3B3 FANCI MTR ATP2A2 PRAME | 6.61e-06 | 1257 | 287 | 27 | 37317656 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | INTS1 TRIP13 PGM3 MDN1 SACS KIF2A IQGAP3 NUMA1 IPO4 VIRMA TOE1 LIG3 AQR TP53BP1 | 7.09e-06 | 400 | 287 | 14 | 35013556 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.74e-06 | 202 | 287 | 10 | 33005030 | |
| Pubmed | CAND1 ZFYVE27 AUP1 VPS13C SRP68 ZNF318 CEP350 DOCK5 VPS13A TASOR GOLGB1 FAT4 RNF213 CEP192 FAM171B IPO4 GTPBP2 LIPE STK33 TOR1AIP1 | 8.59e-06 | 777 | 287 | 20 | 35844135 | |
| Pubmed | MON2 ZEB2 MAGI2 TBC1D1 CHD6 SIPA1L2 FRAS1 SYNE1 CEP192 VIRMA EPG5 GPCPD1 RAB11FIP4 AQR | 8.63e-06 | 407 | 287 | 14 | 12693553 | |
| Pubmed | ATRX CHD3 DOCK5 KIF2A DENND5A TASOR IQGAP3 SLC25A17 HEATR3 FRAS1 POLRMT RDX LIG3 GTPBP2 MTR SLC33A1 AQR SORL1 | 9.23e-06 | 650 | 287 | 18 | 38777146 | |
| Pubmed | CAND1 ATRX INTS1 CHD3 ZEB2 NCAPD2 CHD6 TASOR AHCTF1 NUMA1 TOE1 LIG3 FANCI AQR TP53BP1 | 9.81e-06 | 469 | 287 | 15 | 27634302 | |
| Pubmed | 9.93e-06 | 17 | 287 | 4 | 22411552 | ||
| Pubmed | DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. | 1.09e-05 | 6 | 287 | 3 | 21252315 | |
| Pubmed | 1.09e-05 | 6 | 287 | 3 | 10444070 | ||
| Pubmed | 1.28e-05 | 214 | 287 | 10 | 22199357 | ||
| Pubmed | CAND1 MAN1A1 GHDC AUP1 CYP51A1 INTS1 CEP350 FARSA MDN1 ATP11B NCAPD2 KIF2A HEATR5B SLC25A17 GOLGB1 NPC1 CAD DDX52 RNF213 IPO4 ECPAS CNOT9 FANCI SLC33A1 AQR | 1.56e-05 | 1168 | 287 | 25 | 19946888 | |
| Pubmed | ATRX RTEL1 ZNF318 TEX10 MDN1 ZBTB21 KIF2A IQGAP3 DDX52 FANCI | 1.76e-05 | 222 | 287 | 10 | 37071664 | |
| Pubmed | 1.90e-05 | 7 | 287 | 3 | 31178125 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SPTBN1 OBSCN TEX10 RYR3 IFIH1 MDN1 NCAPD2 KIF2A CARMIL1 POLR2A NUMA1 POLRMT ECPAS TOE1 MYOM2 | 1.93e-05 | 497 | 287 | 15 | 36774506 |
| Pubmed | EPPK1 CENPL VPS13C SPTBN1 SRP68 DOCK5 CHD6 TASOR GOLGB1 WWC1 FAT4 CAD SYNE1 POLR2A DNAH2 ECPAS LIG3 LSM8 SLC33A1 | 1.94e-05 | 754 | 287 | 19 | 35906200 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | CAND1 AUP1 CYP51A1 SRP68 TSC2 TRIP13 FARSA ADSL PMPCA NCAPD2 CAD POLR2A IPO4 FANCI MTR ATP2A2 | 2.52e-05 | 571 | 287 | 16 | 37167062 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.60e-05 | 104 | 287 | 7 | 31240132 | |
| Pubmed | CAND1 SPTBN1 SRP68 TRIP13 MDN1 NCAPD2 KIF2A FLNB CAD DDX52 POLR2A IPO4 ECPAS SF3B3 FANCI CSTF3 ATP2A2 | 2.66e-05 | 638 | 287 | 17 | 33239621 | |
| Pubmed | 2.74e-05 | 71 | 287 | 6 | 33541421 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EPPK1 ATRX SPTBN1 INTS1 SRP68 CHD3 MDN1 KIF22 DDX52 NUMA1 POLRMT LIG3 TP53BP1 | 2.79e-05 | 394 | 287 | 13 | 27248496 |
| Pubmed | 2.95e-05 | 22 | 287 | 4 | 18487259 | ||
| Pubmed | 3.02e-05 | 8 | 287 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.02e-05 | 8 | 287 | 3 | 19033399 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | CUL7 TEX10 TTF1 ZEB2 UBA7 MDN1 ZBTB21 NCAPD2 KIF22 SAMD1 FLNC DDX52 SMARCAL1 POLR2A POLRMT ECPAS LIG3 METTL13 TP53BP1 SORL1 | 3.46e-05 | 857 | 287 | 20 | 25609649 |
| Pubmed | CAND1 NCAPD2 KIF22 AHCTF1 POLR2A NUMA1 RNF213 SF3B3 TOR1AIP1 | 3.83e-05 | 195 | 287 | 9 | 19454010 | |
| Pubmed | Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network. | 3.96e-05 | 111 | 287 | 7 | 32683582 | |
| Pubmed | CAND1 ATRX INTS1 CHD3 TEX10 FARSA MDN1 ZBTB21 NCAPD2 CAD SMARCAL1 POLR2A NUMA1 RNF213 ECPAS VIRMA LIG3 SF3B3 FANCI CSTF3 MPHOSPH8 AQR | 4.19e-05 | 1014 | 287 | 22 | 32416067 | |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | ZNF318 CEP350 FOXRED2 MDN1 PMPCA REEP6 HEATR3 GOLGB1 RDX CLIP4 TOR1AIP1 | 4.23e-05 | 298 | 287 | 11 | 32353859 |
| Pubmed | 4.29e-05 | 153 | 287 | 8 | 10718198 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CAB39 SERPINA3 ATP6V1C1 CAND1 MAN1A1 VPS13C SPTBN1 ADGRV1 HNMT HSPA12A SERPINB13 NDRG1 NPC1 FLNB REXO5 AHCTF1 RDX CUBN TGM4 MBD5 PADI2 SORL1 | 4.31e-05 | 1016 | 287 | 22 | 19056867 |
| Pubmed | CAND1 GALK2 CYP51A1 SRP68 CDK14 ADSL PMPCA HEATR5B MPI TOR1AIP2 FLNB IPO4 ECPAS PDHX DNAAF2 FANCI HARS1 ATP2A2 TOR1AIP1 SLC33A1 | 4.84e-05 | 878 | 287 | 20 | 37223481 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPPK1 CAND1 SPTBN1 SRP68 TSC2 TRIP13 FARSA ADSL NCAPD2 KIF2A GOLGB1 FLNB CAD CARMIL1 POLR2A NUMA1 TTC27 RDX ARHGAP35 TOE1 SF3B3 CNOT9 DDRGK1 ATP2A2 LSM8 AQR AHNAK2 | 5.20e-05 | 1415 | 287 | 27 | 28515276 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | AUP1 VPS13C TMEM135 TSC2 CUL7 MDN1 ADSL PMPCA MIPEP VPS13A KIF2A EXOG GOLGB1 TOR1AIP2 CAD SYNE1 AHCTF1 POLRMT RNF213 PDHX SH3D19 MTR DDRGK1 ATP2A2 TOR1AIP1 PRAME SLC33A1 AHNAK2 | 5.26e-05 | 1496 | 287 | 28 | 32877691 |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 5.40e-05 | 80 | 287 | 6 | 19389623 | |
| Pubmed | SPTBN1 CEP350 RGL1 CHD6 CPLANE1 GOLGB1 GAREM1 FLNC SYNE1 MAP4K5 SH3D19 MAPK6 MBD5 MAP3K21 | 6.02e-05 | 486 | 287 | 14 | 20936779 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 6.31e-05 | 208 | 287 | 9 | 33230847 | |
| Pubmed | 6.39e-05 | 10 | 287 | 3 | 15919184 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MON2 ZNF318 STK11IP CEP350 FOXRED2 MDN1 PMPCA REEP6 HEATR3 GOLGB1 TOR1AIP2 EXOSC1 TTC27 RDX ECPAS CLIP4 FANCI TOR1AIP1 | 6.42e-05 | 754 | 287 | 18 | 33060197 |
| Pubmed | MON2 AUP1 CYP51A1 STK11IP TRIP13 FOXRED2 MDN1 MIPEP HEATR3 NPC1 TOR1AIP2 CAD DOLK PDHX CNOT9 DDRGK1 TOR1AIP1 | 6.52e-05 | 686 | 287 | 17 | 28380382 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 31288808 | ||
| Pubmed | Cleavage of the Arg-Ile bond in the native polypeptide chain of human pancreatic stone protein. | 6.79e-05 | 2 | 287 | 2 | 3108036 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 2764894 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 20489047 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 8522062 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 11956198 | ||
| Pubmed | 15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration. | 6.79e-05 | 2 | 287 | 2 | 18067895 | |
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 19481615 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 23986224 | ||
| Pubmed | 6.79e-05 | 2 | 287 | 2 | 29317594 | ||
| Pubmed | RegII is a beta-cell protein and autoantigen in diabetes of NOD mice. | 6.79e-05 | 2 | 287 | 2 | 17192462 | |
| Pubmed | Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation. | 6.79e-05 | 2 | 287 | 2 | 8654365 | |
| Interaction | OPALIN interactions | MON2 KNTC1 INTS1 TSC2 SLFN5 TRIP13 DOCK5 MDN1 MYO3B AHCTF1 DOLK TTC27 RNF213 ECPAS METTL13 FANCI MAP3K21 ATP2A1 | 8.05e-10 | 209 | 279 | 18 | int:OPALIN |
| Interaction | GPR182 interactions | MON2 KNTC1 CAND1 GHDC AUP1 INTS1 TSC2 TRIP13 DOCK5 MDN1 NCAPD2 EXOG GPAT2 SLC25A17 EXOC6 AHCTF1 TTC27 RNF213 ECPAS METTL13 LIPE FANCI ATP12A PRAME SLC33A1 | 5.39e-09 | 455 | 279 | 25 | int:GPR182 |
| Interaction | RHOF interactions | EPPK1 CAND1 AUP1 SPTBN1 TEX10 HSPA12A MDN1 NDRG1 PTPRG VPS13A NCAPD2 IQGAP3 GOLGB1 KIF22 TOR1AIP2 FAT4 CAD DDX31 DDX52 AHCTF1 PRR5 RDX FAM171B ECPAS LIG3 FANCI ATP2A2 TOR1AIP1 SLC33A1 | 6.87e-08 | 673 | 279 | 29 | int:RHOF |
| Interaction | GPR17 interactions | KNTC1 ZFYVE27 INTS1 TSC2 PGM3 MDN1 SACS NCAPD2 HEATR5B HEATR3 EXOC6 DOLK RNF213 ECPAS ATP12A ATP2A2 SLC33A1 | 4.74e-07 | 283 | 279 | 17 | int:GPR17 |
| Interaction | PFN1 interactions | MON2 KNTC1 CAND1 VPS13C SPTBN1 CUL7 CEP350 KIF2A SIPA1L2 GOLGB1 CARMIL1 RDX BIRC3 CEP192 ARHGAP35 VIRMA DNAAF2 SH3D19 MTR DDRGK1 SLC33A1 TP53BP1 AHNAK2 | 7.42e-07 | 509 | 279 | 23 | int:PFN1 |
| Interaction | BSG interactions | MON2 KNTC1 CAND1 INTS1 SLFN5 TRIP13 DOCK5 HSPA12A ADRB2 MDN1 PIK3CA NCAPD2 GOLGB1 NPC1 RAD51C SAMD1 RNF213 BIRC3 STAM ECPAS VIRMA STK33 DDRGK1 ATP2A1 ATP2A2 AHNAK2 | 7.94e-07 | 631 | 279 | 26 | int:BSG |
| Interaction | RNF123 interactions | ZFYVE27 VPS13C INTS1 OBSCN SRP68 TSC2 SLFN5 ITGAE DOCK5 IFIH1 MDN1 MYO3B VPS13A CHD6 HEATR3 CA12 FLNB FLNC DNAH3 FAT4 POLR2A PCDHB12 DNAH2 MUC19 RNF213 ECPAS ZNF675 LIG3 RDH16 RBM43 | 1.44e-06 | 824 | 279 | 30 | int:RNF123 |
| Interaction | LMBR1L interactions | CAND1 MAN1A1 GHDC AUP1 CYP51A1 SRP68 TSC2 TEX10 TRIP13 PGM3 FARSA FOXRED2 NCAPD2 HEATR5B IQGAP3 HEATR3 NPC1 TOR1AIP2 EXOC6 DDX52 AHCTF1 DNAH2 TTC27 IPO4 ECPAS FANCI MTR CSTF3 DDRGK1 ATP2A2 TOR1AIP1 SLC33A1 | 3.01e-06 | 946 | 279 | 32 | int:LMBR1L |
| Interaction | FAM174A interactions | INTS1 SLFN5 PGM3 HSPA12A HEATR3 RAD51C TOR1AIP2 EXOC6 RNF213 IPO4 METTL13 FANCI ATP12A PRAME | 3.12e-06 | 224 | 279 | 14 | int:FAM174A |
| Interaction | NUP155 interactions | MON2 EPPK1 AUP1 ENTR1 TSC2 CUL7 TRIP13 ADRB2 GOLGB1 TOR1AIP2 AHCTF1 NUMA1 BIRC3 REG1B CEP192 VIRMA DDRGK1 ATP2A1 ATP2A2 TOR1AIP1 SLC33A1 | 3.43e-06 | 477 | 279 | 21 | int:NUP155 |
| Interaction | LGR4 interactions | TPTE CYP51A1 CHD3 IQGAP3 NPC1 CAD POLR2A NUMA1 POLRMT VIRMA PDHX SF3B3 ATP2A1 ATP2A2 AQR | 4.08e-06 | 262 | 279 | 15 | int:LGR4 |
| Interaction | LAMP3 interactions | KNTC1 AUP1 VPS13C SPTBN1 TSC2 SLFN5 STK11IP HSPA12A MDN1 PTPRG ATP11C GOLGB1 TOR1AIP2 AHCTF1 RNF213 STAM METTL13 FANCI DDRGK1 TOR1AIP1 SLC33A1 | 4.58e-06 | 486 | 279 | 21 | int:LAMP3 |
| Interaction | CHODL interactions | 5.40e-06 | 33 | 279 | 6 | int:CHODL | |
| Interaction | KCNA3 interactions | EPPK1 AUP1 ABCA13 SPEF2 SPTBN1 SRP68 FARSA NDRG1 VPS13A NCAPD2 IQGAP3 GOLGB1 FLNB CAD CARMIL1 AHCTF1 DOLK NUMA1 RDX RNF213 STAM ECPAS SF3B3 MAP4K5 FANCI SH3D19 MAP3K21 ATP2A2 SORL1 | 1.22e-05 | 871 | 279 | 29 | int:KCNA3 |
| Interaction | MGARP interactions | MON2 INTS1 STK11IP HSPA12A SLC25A17 RAD51C AHCTF1 TTC27 RNF213 ECPAS FANCI STK33 ATP12A | 1.41e-05 | 222 | 279 | 13 | int:MGARP |
| Interaction | SIRT7 interactions | EPPK1 SPTBN1 INTS1 SRP68 ZNF318 CUL7 TEX10 TTF1 MDN1 NCAPD2 FLNB FLNC CAD DDX31 DDX52 AHCTF1 POLR2A NUMA1 POLRMT IPO4 ECPAS VIRMA FANCI ATP2A2 AQR TP53BP1 | 1.54e-05 | 744 | 279 | 26 | int:SIRT7 |
| Interaction | ARRDC4 interactions | 1.96e-05 | 83 | 279 | 8 | int:ARRDC4 | |
| Interaction | DKKL1 interactions | 2.42e-05 | 111 | 279 | 9 | int:DKKL1 | |
| Interaction | SUMO2 interactions | EPPK1 ATRX SPTBN1 SRP68 CHD3 TEX10 TRIP13 ABCA8 MDN1 ZBTB21 NCAPD2 KIF2A MPI FLNB CAD POLR2A NUMA1 RNF213 CCNE2 MAPK6 TP53BP1 AHNAK2 | 2.78e-05 | 591 | 279 | 22 | int:SUMO2 |
| Interaction | VIPR1 interactions | GPRASP1 AUP1 INTS1 PGM3 REEP6 SLC25A17 NPC1 MROH2A TTC27 ECPAS ATP12A SLC33A1 | 3.04e-05 | 205 | 279 | 12 | int:VIPR1 |
| Interaction | NPTN interactions | MON2 KNTC1 INTS1 TSC2 HSPA12A MDN1 HEATR5B EXOC6 RNF213 IPO4 ECPAS ATP2A1 ATP2A2 PRAME | 3.58e-05 | 278 | 279 | 14 | int:NPTN |
| Interaction | APLNR interactions | CAND1 AUP1 INTS1 PGM3 MDN1 TOR1AIP2 EXOC6 DOLK ECPAS METTL13 ATP12A SLC33A1 | 4.03e-05 | 211 | 279 | 12 | int:APLNR |
| Interaction | CCDC8 interactions | EPPK1 CAND1 INTS1 CHD3 ZNF318 CUL7 TRIP13 CEP350 MDN1 SACS ZBTB21 HEATR5B GOLGB1 FLNB CAD MROH2A POLR2A PCDHB11 NUMA1 LIG3 SF3B3 ATP2A2 TOR1AIP1 | 4.61e-05 | 656 | 279 | 23 | int:CCDC8 |
| Interaction | CIT interactions | GPRASP1 EPPK1 GHDC AUP1 SPTBN1 INTS1 SRP68 CHD3 ADGRV1 CUL7 TEX10 TRIP13 KIF2A WWC1 FLNB FLNC CAD DDX31 SYNE1 AHCTF1 POLR2A NUMA1 RNF213 ECPAS VIRMA TOE1 LIG3 SF3B3 FANCI CSTF3 MPHOSPH8 MYOM2 HARS1 ATP2A1 ATP2A2 LSM8 TOR1AIP1 AQR AHNAK2 | 5.07e-05 | 1450 | 279 | 39 | int:CIT |
| Interaction | SLX4 interactions | CAND1 ATRX RTEL1 ZNF318 TEX10 ZEB2 CEP350 MDN1 ZBTB21 KIF2A IQGAP3 CAD DDX52 POLR2A NUMA1 DCLRE1B VIRMA SF3B3 FANCI ATP2A2 TP53BP1 | 5.17e-05 | 572 | 279 | 21 | int:SLX4 |
| Interaction | RHOA interactions | EPPK1 AUP1 VPS13C SPTBN1 CYP51A1 STK11IP HSPA12A MDN1 PTPRG VPS13A IQGAP3 SLC25A17 GOLGB1 KIF22 NPC1 TOR1AIP2 FAT4 CAD DDX31 DDX52 POLRMT BIRC3 ARHGAP35 FAM171B IPO4 VIRMA PDHX TOE1 ARHGDIG DDRGK1 MBD5 ATP2A2 TOR1AIP1 SLC33A1 | 5.80e-05 | 1199 | 279 | 34 | int:RHOA |
| Interaction | IQCF1 interactions | 6.36e-05 | 50 | 279 | 6 | int:IQCF1 | |
| Interaction | CLEC16A interactions | MON2 CAND1 AUP1 ENTR1 TSC2 STK11IP TRIP13 MDN1 PMPCA VPS13A NCAPD2 KIF2A SIPA1L2 IQGAP3 TOR1AIP2 EXOC6 TTC27 IPO4 VIRMA METTL13 FANCI MTR | 7.00e-05 | 629 | 279 | 22 | int:CLEC16A |
| Interaction | FASN interactions | MON2 CAND1 AUP1 TSC2 CUL7 TRIP13 PGM3 NDRG1 USP38 PIK3CA KICS2 HEATR3 SAMD1 FLNB FLNC CAD SMARCAL1 EXOSC1 BIRC3 VPS54 VIRMA GTPBP2 SF3B3 MYLIP NCOA1 DDRGK1 MPHOSPH8 MAPK6 MBD5 SLC33A1 TP53BP1 | 7.44e-05 | 1062 | 279 | 31 | int:FASN |
| Interaction | TPTE interactions | 7.91e-05 | 129 | 279 | 9 | int:TPTE | |
| Interaction | IL13RA2 interactions | 1.19e-04 | 136 | 279 | 9 | int:IL13RA2 | |
| Interaction | ATOH1 interactions | 1.21e-04 | 80 | 279 | 7 | int:ATOH1 | |
| Interaction | TRIM66 interactions | MON2 ZNF318 CUL7 SIPA1L2 SAMD1 AHCTF1 TTC27 RNF213 METTL13 GTPBP2 MTR | 1.41e-04 | 205 | 279 | 11 | int:TRIM66 |
| Interaction | NSUN5P1 interactions | 1.62e-04 | 59 | 279 | 6 | int:NSUN5P1 | |
| Interaction | SIGLECL1 interactions | 1.78e-04 | 113 | 279 | 8 | int:SIGLECL1 | |
| Interaction | EEF1AKMT3 interactions | KNTC1 RTEL1 VPS13C TSC2 SLFN5 CUL7 DOCK5 MDN1 NCAPD2 GPAT2 SAMD1 SMARCAL1 METTL13 MTR AQR | 1.81e-04 | 364 | 279 | 15 | int:EEF1AKMT3 |
| GeneFamily | Dyneins, axonemal | 5.64e-07 | 17 | 183 | 5 | 536 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 1.59e-04 | 11 | 183 | 3 | 1168 | |
| GeneFamily | ATP binding cassette subfamily A | 3.42e-04 | 14 | 183 | 3 | 805 | |
| GeneFamily | ATPase phospholipid transporting | 4.24e-04 | 15 | 183 | 3 | 1210 | |
| GeneFamily | Cadherin related | 6.25e-04 | 17 | 183 | 3 | 24 | |
| GeneFamily | Arachidonate lipoxygenases | 1.49e-03 | 6 | 183 | 2 | 407 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.49e-03 | 181 | 183 | 7 | 694 | |
| GeneFamily | Cyclins | 2.77e-03 | 28 | 183 | 3 | 473 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 3.39e-03 | 30 | 183 | 3 | 959 | |
| GeneFamily | Transglutaminases | 3.50e-03 | 9 | 183 | 2 | 773 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 3.50e-03 | 9 | 183 | 2 | 1230 | |
| GeneFamily | ATPases Ca2+ transporting | 3.50e-03 | 9 | 183 | 2 | 1209 | |
| Coexpression | FISCHER_DREAM_TARGETS | KNTC1 CAND1 CENPL CYP51A1 RDM1 TTF1 TRIP13 IFIH1 NCAPD2 KIF2A IQGAP3 MACIR KIF22 DNMT3B RAD51C CAD AHCTF1 RDX CEP192 DCLRE1B TOE1 CCNE1 DDIAS GTPBP2 SF3B3 CNOT9 FANCI LRRCC1 TOR1AIP1 C4orf46 | 2.75e-07 | 969 | 284 | 30 | M149 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | FAM114A1 INTS1 HSPA12A PMPCA FLNC CAD POLR2A ARHGAP35 CCNE1 METTL13 MYOM2 ATP2A2 PRAME AQR SORL1 | 3.93e-07 | 276 | 284 | 15 | M3063 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CAND1 GALK2 ATRX ZEB2 CEP350 RGL1 MDN1 ATP11B SACS VPS13A KIF2A DENND5A TASOR WWC1 NSMAF RAD51C FLNB AHCTF1 RDX STAM ARHGAP35 MAP4K5 MTR NCOA1 MAPK6 AQR TP53BP1 | 7.89e-07 | 856 | 284 | 27 | M4500 |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | KNTC1 SPTBN1 SLFN5 TRIP13 FOXRED2 NDRG1 NCAPD2 KIF22 RAD51C RNF213 CEP192 FANCI | 2.08e-06 | 200 | 284 | 12 | M7143 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN | MON2 TRIP13 LYST PGM3 FARSA FOXRED2 ADRB2 ATP11B PMPCA SACS EBPL TBC1D1 MPI TOR1AIP2 DDX31 NTHL1 PRR5 B3GNT7 IPO4 DNAAF2 DDIAS ARHGDIG STK33 MYLIP NCOA1 AQR SORL1 | 5.52e-06 | 950 | 284 | 27 | M19907 |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP | MAN1A1 MAGI2 PMPCA MACIR FLNB LIG3 CNOT9 MAP4K5 NCOA1 MPHOSPH8 ATP2A2 | 1.05e-05 | 196 | 284 | 11 | M5256 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | AADAC ATP6V1C1 NCF2 CUL7 LYST ZEB2 PGM3 RGL1 NDRG1 PIK3CA SMOX GOLGB1 NSMAF GAREM1 DNMT3B NPC1 STAM GTPBP2 MAP4K5 CSTF3 NCOA1 SLC33A1 IL6 AHNAK2 | 1.21e-05 | 822 | 284 | 24 | M6782 |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | MAN1A1 SLFN5 LYST NCAPD2 NSMAF CACNA1S CARMIL1 BIRC3 CCNE2 MAP4K5 TMEM35B | 1.27e-05 | 200 | 284 | 11 | M7168 |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | GPRASP1 ABCA13 TMEM135 RAD51C BIRC3 VIRMA ATP10D CYP2R1 LRRCC1 SLC33A1 C4orf46 | 1.27e-05 | 200 | 284 | 11 | M7505 |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN | ZEB2 DOCK5 SERPINI1 IQGAP3 MACIR FLNB DOLK DNAAF2 DDIAS MAP3K21 PADI2 | 1.27e-05 | 200 | 284 | 11 | M9292 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | FAM114A1 CENPL TMEM135 RDM1 TRIP13 ABCA8 DOCK5 HSPA12A FOXRED2 PIK3CA MIPEP NCAPD2 ROBO3 SIPA1L2 IQGAP3 WWC1 ALOX15 REXO5 DOLK CEP192 DCLRE1B CCNE1 ZNF675 CCNE2 SH3D19 USP40 LRRCC1 TMEM35B | 1.28e-05 | 1054 | 284 | 28 | M45798 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | SPEF2 ADGRV1 MDN1 PTPRG PCDH15 CHD6 GOLGB1 FRAS1 DNAH2 CUBN PDHX AGXT2 TMEM232 CYP2R1 RORA ATP2A2 | 1.46e-05 | 417 | 284 | 16 | M39224 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | MAN1A1 CDK14 PTPRG BICC1 WDR72 CA12 FRAS1 MTR NCOA1 RORA MBD5 | 1.83e-05 | 208 | 284 | 11 | M39233 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN | MON2 TRIP13 LYST ZEB2 FARSA FOXRED2 ADRB2 ATP11B PMPCA SACS EBPL TBC1D1 MIPEP MPI TOR1AIP2 DDX31 NTHL1 PRR5 B3GNT7 IPO4 DNAAF2 DDIAS ARHGDIG STK33 MYLIP AQR SORL1 | 2.98e-05 | 1045 | 284 | 27 | M8525 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | CDK14 PTPRG VPS13A PCDH15 GOLGB1 WDR72 FRAS1 CUBN AGXT2 RORA MBD5 | 3.20e-05 | 221 | 284 | 11 | M39222 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CAB39 MAN1A1 ATRX VPS13C SPEF2 CHD3 SLFN5 ITGAE LYST ZEB2 CEP350 ATP11B SACS TBC1D1 KIF2A TASOR NSMAF SYNE1 NUMA1 RNF213 BIRC3 NLRP1 ARHGAP35 EPG5 SF3B3 MYLIP MTR GPCPD1 NCOA1 RORA MPHOSPH8 TMEM35B TOR1AIP1 SORL1 | 3.58e-05 | 1492 | 284 | 34 | M40023 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KNTC1 CENPL TRIP13 NCAPD2 IQGAP3 KIF22 WDR72 RAD51C CLIP4 CCNE1 DDIAS CNOT9 CCNE2 FANCI C4orf46 | 3.71e-05 | 402 | 284 | 15 | MM454 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | CCNI2 CENPL CHD3 CUL7 ITGAE TRIP13 SERPINI1 NDRG1 PTPRG SACS SCG2 NCAPD2 HFM1 KIF2A ALOX15B NSMAF DNMT3B CACNA1S CHST10 FRAS1 ATP10D MTR TP53BP1 C4orf46 | 4.39e-05 | 891 | 284 | 24 | M45033 |
| Coexpression | DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS | DGCR6 OBSCN KLHL41 DNAH8 CACNA1S KLHL40 ECPAS MYOM2 ATP2A1 PADI2 | 5.44e-05 | 194 | 284 | 10 | M40093 |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | ZNF318 ZEB2 MAGI2 VPS13A SMOX MS4A6A CARMIL1 DNAAF2 FANCI GLCE | 6.19e-05 | 197 | 284 | 10 | M8980 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MAN1A1 SLFN5 LYST ZEB2 DOCK5 MAGI2 HSPA12A SERPINI1 PTPRG PIK3CA TBC1D1 VPS13A HEATR5B TASOR NSMAF TOR1AIP2 VPS54 ECPAS RDH16 RORA MYOM2 MBD5 SLC33A1 | 6.36e-05 | 854 | 284 | 23 | M1533 |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_DC_DN | 6.46e-05 | 198 | 284 | 10 | M5208 | |
| Coexpression | GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN | 6.73e-05 | 199 | 284 | 10 | M9846 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | CAB39 MAN1A1 SLFN5 IFIH1 UBA7 ADRB2 TRPV3 HEPHL1 NPC1 BIRC3 B3GNT7 TOR1AIP1 IL6 RBM43 | 7.29e-05 | 378 | 284 | 14 | M34022 |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | KNTC1 CENPL RDM1 TRIP13 ZEB2 SACS NCAPD2 KIF2A KIF22 DNMT3B REXO5 DCLRE1B DDIAS LIG3 CCNE2 FANCI LRRCC1 C4orf46 | 8.39e-05 | 588 | 284 | 18 | M38992 |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN | 1.05e-04 | 170 | 284 | 9 | M6762 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 VPS13C JAKMIP2 CEP350 IFIH1 SACS PIK3CA CPLANE1 TASOR GOLGB1 GAREM1 AHCTF1 RDX CEP192 MTR RORA MPHOSPH8 MAPK6 SORL1 | 1.10e-04 | 656 | 284 | 19 | M18979 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MAN1A1 SLFN5 LYST ZEB2 DOCK5 MAGI2 HSPA12A SERPINI1 PTPRG PIK3CA TBC1D1 VPS13A HEATR5B TASOR NSMAF TOR1AIP2 VPS54 ECPAS RDH16 RORA MYOM2 MBD5 SLC33A1 | 1.14e-04 | 888 | 284 | 23 | MM1018 |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | KNTC1 ATP6V1C1 GALK2 CENPL RDM1 CDK14 TBC1D1 NCAPD2 KICS2 IQGAP3 KIF22 RAD51C CAD DNAH2 FAM171B CCNE1 DDIAS CNOT9 CCNE2 FANCI GLCE LRRCC1 GPCPD1 CSTF3 RAB11FIP4 | 1.42e-04 | 1023 | 284 | 25 | M17122 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | CAB39 CENPL ENTR1 DNAAF11 STK11IP SLC26A8 PMPCA MS4A6A NPC1 CA12 TOR1AIP2 CAD MARCHF9 NUMA1 BIRC3 DCLRE1B ECPAS ATP10D DDIAS METTL13 GTPBP2 GLCE MPHOSPH8 MAPK6 TOR1AIP1 | 1.44e-04 | 1024 | 284 | 25 | M1742 |
| Coexpression | LEE_BMP2_TARGETS_DN | RTEL1 CYP51A1 TRIP13 MDN1 PTPRG PMPCA SACS HEATR3 MPI CAD AHSA2P THEM5 POLRMT EXOSC1 CEP192 DCLRE1B CCNE1 DNAAF2 SF3B3 CCNE2 CSTF3 MAPK6 LSM8 | 1.48e-04 | 904 | 284 | 23 | M2325 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KNTC1 CAND1 CENPL RTEL1 TRIP13 JAKMIP2 FOXRED2 NRXN1 NCAPD2 EXOG IQGAP3 KIF22 CCNE1 CNOT9 CCNE2 FANCI CSTF3 TP53BP1 C4orf46 | 1.75e-04 | 680 | 284 | 19 | MM456 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATRX CEP350 MDN1 ADSL ATP11B VPS13A KIF2A DENND5A TASOR WWC1 FLNB STAM MAP4K5 NCOA1 MAPK6 | 1.91e-04 | 466 | 284 | 15 | M13522 |
| Coexpression | LEE_BMP2_TARGETS_DN | RTEL1 CYP51A1 TRIP13 MDN1 PTPRG PMPCA SACS HEATR3 MPI CAD AHSA2P THEM5 POLRMT EXOSC1 CEP192 DCLRE1B CCNE1 DNAAF2 SF3B3 CCNE2 CSTF3 MAPK6 LSM8 | 1.96e-04 | 922 | 284 | 23 | MM1068 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 ZNF318 TEX10 LYST MDN1 ATP11B VPS13A ATP11C HFM1 CPLANE1 DNAH8 GPAT2 NPC1 RAD51C CAD REXO5 TTC27 CEP192 CUBN STK31 CCNE1 USP26 DDIAS SF3B3 CYP2R1 CCNE2 FANCI GLCE USP40 MTR | 4.84e-07 | 820 | 280 | 30 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | KNTC1 ATP6V1C1 TEX10 TRIP13 MDN1 ADSL ATP11B VPS13A HFM1 CPLANE1 DNAH8 TRDMT1 NPC1 RAD51C CAD MUC19 TTC27 RNF213 CEP192 CUBN STK31 CCNE1 USP26 DDIAS SF3B3 FANCI MTR | 1.34e-05 | 822 | 280 | 27 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | CAND1 TRIP13 PIK3CA ZBTB21 KIF2A FAT4 PCDHB12 DCLRE1B STAM MAP4K5 GLCE RORA LSM8 AQR C4orf46 | 1.54e-05 | 307 | 280 | 15 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | CAND1 ATRX ADGRV1 TRIP13 HNMT IFIH1 RGL1 PIK3CA ZBTB21 KIF2A FAT4 PCDHB12 ABCC9 VPS54 DCLRE1B STAM CCNE1 DDIAS MAP4K5 GLCE COMMD7 RORA MYOM2 LSM8 AQR C4orf46 | 3.48e-05 | 819 | 280 | 26 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | KNTC1 ZNF318 TEX10 MDN1 ATP11B VPS13A HFM1 CPLANE1 DNAH8 RAD51C CAD STK31 USP26 DDIAS CYP2R1 FANCI | 5.73e-05 | 385 | 280 | 16 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_500 | CYP51A1 ZEB2 UTY FAT4 PCDHB12 PCDHB11 MAP4K5 FAM199X C4orf46 | 6.54e-05 | 132 | 280 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 OBSCN ADGRV1 NKAIN2 RYR3 NRXN1 PCDH15 MGAM FAT4 FRAS1 STXBP5L MROH2A DNAH1 UNC13C MYOM2 DNAH11 | 4.26e-15 | 184 | 285 | 17 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 OBSCN ADGRV1 NKAIN2 RYR3 NRXN1 PCDH15 MGAM FAT4 FRAS1 STXBP5L MROH2A DNAH1 UNC13C MYOM2 DNAH11 | 4.26e-15 | 184 | 285 | 17 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 OBSCN ADGRV1 NKAIN2 RYR3 NRXN1 PCDH15 MGAM FAT4 FRAS1 STXBP5L MROH2A DNAH1 UNC13C MYOM2 DNAH11 | 4.26e-15 | 184 | 285 | 17 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ADGRV1 RYR3 MYO3B PCDH15 FRAS1 MROH2A POLR2A CUBN DNAH1 UNC13C ATP12A IL6 DNAH11 | 5.18e-12 | 169 | 285 | 14 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SPTBN1 NKAIN2 ZEB2 DOCK5 MAGI2 PTPRG FAT4 CARMIL1 GLCE RORA UNC13C MBD5 | 5.29e-09 | 195 | 285 | 12 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | ABCA13 NKAIN2 SGCZ SLC26A8 NRXN1 PCDH15 TRPV3 STXBP5L DNAH2 TMEM132D | 3.69e-08 | 146 | 285 | 10 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | MON2 VPS13C ZEB2 GOLGB1 AHCTF1 RNF213 REG1A EPG5 GPCPD1 RORA TP53BP1 | 3.89e-08 | 188 | 285 | 11 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ABCA13 SPEF2 ADGRV1 CFAP65 CPLANE1 ALOX15 DNAH3 DNAH2 ICA1L AHNAK2 DNAH11 | 5.09e-08 | 193 | 285 | 11 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | BICC1 WWC1 GAREM1 WDR72 CA12 FRAS1 CUBN TMEM232 STK33 MTR RORA | 5.09e-08 | 193 | 285 | 11 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | KNTC1 CENPL RTEL1 TMEM135 NCAPD2 ALOX15 RAD51C FLNB CCNE1 CCNE2 | 2.25e-07 | 177 | 285 | 10 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | VPS13C TASOR ALOX15 ALOX15B NSMAF NPC1 FLNB ATP2A1 PADI2 IL6 | 2.77e-07 | 181 | 285 | 10 | 7286700396676fdc41d9723979b8b408177aceb9 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA4 ABCA13 MAGI2 PTPRG BICC1 WWC1 FRAS1 SYNE1 TMEM132D DNAH11 | 3.56e-07 | 186 | 285 | 10 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | MON2 KNTC1 VPS13C CYP51A1 LYST ZEB2 UTY AHCTF1 RNF213 GPCPD1 | 4.55e-07 | 191 | 285 | 10 | 9454f642c3621370fa23640b631301346b300950 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-07 | 192 | 285 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | ABCA13 SPEF2 DNAAF11 TRIP13 CFAP65 ALOX15 DNAH3 TMEM232 STK33 DNAH11 | 5.00e-07 | 193 | 285 | 10 | a0baa8be6f590b2031fede22be588715ae458e93 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | NKAIN2 ABCA8 MAGI2 PTPRG PCDH15 BICC1 FAT4 FRAS1 RORA UNC13C | 5.00e-07 | 193 | 285 | 10 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MYO3B BICC1 WWC1 GAREM1 WDR72 CA12 FRAS1 TMEM232 STK33 MAP3K21 | 5.25e-07 | 194 | 285 | 10 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CDK14 NKAIN2 ABCA8 MAGI2 PTPRG PCDH15 BICC1 FAT4 RORA UNC13C | 5.25e-07 | 194 | 285 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | SPTBN1 NKAIN2 ZEB2 DOCK5 PTPRG FAT4 CARMIL1 GLCE RORA UNC13C | 5.25e-07 | 194 | 285 | 10 | b1bb0f846d2865efdd9bc8842b16b9d069785882 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-07 | 195 | 285 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-07 | 195 | 285 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | ABCA13 SPTBN1 PTPRG WWC1 DNAH3 SYNE1 TMEM232 STK33 RORA DNAH11 | 5.76e-07 | 196 | 285 | 10 | 6d02d494196e3f857d53eea46d9419690d43beca |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | ABCA13 SPTBN1 PTPRG WWC1 DNAH3 SYNE1 TMEM232 STK33 RORA DNAH11 | 5.76e-07 | 196 | 285 | 10 | af4cdc61830685a888a1209826c23bcf54a43084 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | SPTBN1 NKAIN2 ABCA8 ZEB2 BICC1 FAT4 CARMIL1 SH3D19 RORA UNC13C | 6.04e-07 | 197 | 285 | 10 | 11a4c417f035e554431a8f03be13b5eefa3530c0 |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 6.93e-07 | 200 | 285 | 10 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.93e-07 | 200 | 285 | 10 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Control-Epithelial_airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SERPINA3 ADGRV1 JAKMIP2 CFAP65 SGCZ ADGRF4 GAREM1 DNAH3 DNAH11 | 8.52e-07 | 158 | 285 | 9 | 35aee1c3b92169e73569331022833cb44ab7e7e8 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 160 | 285 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 160 | 285 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-06 | 165 | 285 | 9 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-06 | 165 | 285 | 9 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 166 | 285 | 9 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 166 | 285 | 9 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 171 | 285 | 9 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 176 | 285 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-06 | 179 | 285 | 9 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.51e-06 | 180 | 285 | 9 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CENPL SPEF2 NCAPD2 IQGAP3 KIF22 STXBP5L SPATA24 FANCI C4orf46 | 2.75e-06 | 182 | 285 | 9 | 0fc45214f0b0766f69be6eff69cc4bec574023aa |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-06 | 183 | 285 | 9 | 42dc31d587fbb9724b2f0be5ee8ed77233f67b86 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-06 | 183 | 285 | 9 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 184 | 285 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.14e-06 | 185 | 285 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.29e-06 | 186 | 285 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.43e-06 | 187 | 285 | 9 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 187 | 285 | 9 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.59e-06 | 188 | 285 | 9 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA13 SPEF2 DNAAF11 CFAP65 DNAH3 DNAH2 TMEM232 STK33 DNAH11 | 4.08e-06 | 191 | 285 | 9 | 1c528f72c9ef3ef3a850b05e4a9715190832270c |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA13 SPEF2 DNAAF11 CFAP65 DNAH3 DNAH2 TMEM232 STK33 DNAH11 | 4.08e-06 | 191 | 285 | 9 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ABCA13 SPEF2 DNAAF11 CFAP65 DNAH3 DNAH2 TMEM232 STK33 DNAH11 | 4.08e-06 | 191 | 285 | 9 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | GHDC ATP11B ZBTB21 SLC25A17 SPATA24 B3GNT7 CYP2R1 ICA1L EPB42 | 4.26e-06 | 192 | 285 | 9 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.44e-06 | 193 | 285 | 9 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.44e-06 | 193 | 285 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 193 | 285 | 9 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-06 | 194 | 285 | 9 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 4.63e-06 | 194 | 285 | 9 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.83e-06 | 195 | 285 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-06 | 195 | 285 | 9 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-06 | 196 | 285 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-06 | 196 | 285 | 9 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.03e-06 | 196 | 285 | 9 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 5.15e-06 | 148 | 285 | 8 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.15e-06 | 148 | 285 | 8 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.25e-06 | 197 | 285 | 9 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.25e-06 | 197 | 285 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.25e-06 | 197 | 285 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.47e-06 | 198 | 285 | 9 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 5.47e-06 | 198 | 285 | 9 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.47e-06 | 198 | 285 | 9 | 1e43181c13e054570046c7a973ddc1c586e259b0 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 5.47e-06 | 198 | 285 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.47e-06 | 198 | 285 | 9 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.47e-06 | 198 | 285 | 9 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.47e-06 | 198 | 285 | 9 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.68e-06 | 150 | 285 | 8 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 199 | 285 | 9 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 5.69e-06 | 199 | 285 | 9 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.69e-06 | 199 | 285 | 9 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | ANKRD31 DNAAF11 CFAP65 DNAH3 DNAH2 DNAH1 ARHGDIG STK33 ATP12A | 5.69e-06 | 199 | 285 | 9 | 15f7814b7074170eee7ccacaa670b1d128fc68bb |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.69e-06 | 199 | 285 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.69e-06 | 199 | 285 | 9 | 85b3b1ad01368dae4adbc9da7efc148e49992f69 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.69e-06 | 199 | 285 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.69e-06 | 199 | 285 | 9 | c7d6a8398f2419b726a0461585d1ee0561654e3b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 199 | 285 | 9 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 5.93e-06 | 200 | 285 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | SPEF2 DNAAF11 TRIP13 CFAP65 ALOX15 DNAH3 TMEM232 STK33 DNAH11 | 5.93e-06 | 200 | 285 | 9 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.93e-06 | 200 | 285 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | (18)_cycling_gd_T|World / shred on Cell_type and subtype | 6.69e-06 | 203 | 285 | 9 | 7d58929058c4769226a29febee1fd8ba64bc9f1a | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.23e-06 | 155 | 285 | 8 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | facs-Trachea-nan-3m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-06 | 157 | 285 | 8 | 0fecc14959c4c9efc19d5c06475a890e0a30f148 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-06 | 158 | 285 | 8 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.72e-06 | 159 | 285 | 8 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 159 | 285 | 8 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 159 | 285 | 8 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-06 | 162 | 285 | 8 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 163 | 285 | 8 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 164 | 285 | 8 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 165 | 285 | 8 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 167 | 285 | 8 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-05 | 169 | 285 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 169 | 285 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-05 | 169 | 285 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| Drug | AC1L1BG8 | 1.94e-06 | 3 | 285 | 3 | CID000001425 | |
| Drug | 3-isoreserpine | ABCA4 ABCA13 ABCA8 ADRB2 PIK3CA SCG2 VPS13A DENND5A ABCC9 USP26 SF3B3 SORL1 | 5.27e-06 | 190 | 285 | 12 | CID000005052 |
| Drug | AC1L1IZE | CYP51A1 RYR3 DNAH8 MGAM DNAH3 DNAH1 ATP2A1 ATP2A2 IL6 DNAH11 | 6.14e-06 | 131 | 285 | 10 | CID000004799 |
| Drug | methylxylocholine | 7.69e-06 | 4 | 285 | 3 | CID000009693 | |
| Disease | Malignant neoplasm of breast | TPTE ABCA4 ADAT3 OBSCN ZNF318 ZEB2 RGL1 NDRG1 PIK3CA ADGRF4 SMOX MACIR GOLGB1 DNMT3B RAD51C FLNB SYNE1 SMARCAL1 AHSA2P CUBN EPG5 CCNE1 LIPE MTR NCOA1 TOR1AIP1 IL6 TP53BP1 SORL1 | 3.09e-07 | 1074 | 274 | 29 | C0006142 |
| Disease | Colorectal Carcinoma | ABCA4 ABCA13 OBSCN JAKMIP2 ABCA8 ZEB2 SACS PIK3CA VPS13A ATP11C DNAH8 FLNC DNAH3 CAD SYNE1 NTHL1 STAM CUBN LIG3 SLC33A1 SORL1 | 3.00e-06 | 702 | 274 | 21 | C0009402 |
| Disease | Ciliopathies | 9.03e-06 | 110 | 274 | 8 | C4277690 | |
| Disease | calcium measurement | ANKRD31 SPTBN1 ZNF318 SHOC1 HFM1 SLC25A17 GOLGB1 STXBP5L AHSA2P NUMA1 DNAH2 CCNE1 MAP4K5 USP40 GPCPD1 RORA ATP2A2 IL6 | 2.72e-05 | 628 | 274 | 18 | EFO_0004838 |
| Disease | aspartate aminotransferase measurement | ANKRD31 ABCA4 OBSCN RGL1 HSPA12A HMCN2 HEPHL1 TRDMT1 CACNA1S FLNB CARMIL1 DNAH2 MUC19 RNF213 STAM ARHGAP35 CUBN CCNE1 TMEM132D MAP4K5 STK33 RORA | 4.27e-05 | 904 | 274 | 22 | EFO_0004736 |
| Disease | Primary Ciliary Dyskinesia | 7.42e-05 | 47 | 274 | 5 | C4551720 | |
| Disease | bilirubin measurement | FAM114A1 CHD3 MIPEP EXOC6 FAT4 MROH2A CARMIL1 TTC27 ABCC9 MAP4K5 USP40 RORA IL6 DNAH11 | 7.54e-05 | 442 | 274 | 14 | EFO_0004570 |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 8.59e-05 | 2 | 274 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 8.59e-05 | 2 | 274 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of the head and neck | 1.21e-04 | 52 | 274 | 5 | C1168401 | |
| Disease | phosphatidylcholine 34:1 measurement | 1.24e-04 | 11 | 274 | 3 | EFO_0010375 | |
| Disease | Epileptic encephalopathy | 1.65e-04 | 30 | 274 | 4 | C0543888 | |
| Disease | Ventricular Dysfunction, Left | 1.65e-04 | 30 | 274 | 4 | C0242698 | |
| Disease | velocity of sound measurement | 2.11e-04 | 13 | 274 | 3 | EFO_0005654 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 2.56e-04 | 3 | 274 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 2.56e-04 | 3 | 274 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Brody myopathy (implicated_via_orthology) | 2.56e-04 | 3 | 274 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 2.56e-04 | 3 | 274 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 2.56e-04 | 3 | 274 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | alcohol consumption measurement | SPTBN1 ADGRV1 ACVR2B MAGI2 SGCZ NRXN1 KIF2A EXOG WWC1 DNMT3B NPC1 MGAM CAD DDX31 DNAH2 CLIP4 CCNE1 MAP4K5 STK33 COMMD7 CSTF3 RAB11FIP4 MAPK6 LSM8 SORL1 | 2.59e-04 | 1242 | 274 | 25 | EFO_0007878 |
| Disease | triacylglycerol 46:2 measurement | 2.67e-04 | 14 | 274 | 3 | EFO_0010402 | |
| Disease | Primary ciliary dyskinesia | 3.39e-04 | 36 | 274 | 4 | cv:C0008780 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.84e-04 | 148 | 274 | 7 | C0279702 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 5.09e-04 | 4 | 274 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Usher Syndrome | 5.09e-04 | 4 | 274 | 2 | C0271097 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 5.11e-04 | 40 | 274 | 4 | EFO_0004746 | |
| Disease | Glioblastoma Multiforme | 6.09e-04 | 111 | 274 | 6 | C1621958 | |
| Disease | urate measurement | CHD3 ZNF318 ADGRV1 USP38 NRXN1 MYO3B HFM1 HEATR5B BICC1 CA12 DNAH3 CARMIL1 CUBN DNAH1 CCNE1 ZNF675 MAP4K5 MBD5 LSM8 | 7.67e-04 | 895 | 274 | 19 | EFO_0004531 |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 8.43e-04 | 5 | 274 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | proline measurement, amino acid measurement | 8.43e-04 | 5 | 274 | 2 | EFO_0005134, EFO_0009773 | |
| Disease | whole-brain volume | 8.43e-04 | 5 | 274 | 2 | EFO_0005089 | |
| Disease | hypertension (is_implicated_in) | 9.57e-04 | 121 | 274 | 6 | DOID:10763 (is_implicated_in) | |
| Disease | progression free survival, ovarian serous carcinoma | 1.07e-03 | 22 | 274 | 3 | EFO_0004920, EFO_1001516 | |
| Disease | GlcNAc sulfate conjugate of C21H34O2 steroid measurement | 1.26e-03 | 6 | 274 | 2 | EFO_0800663 | |
| Disease | Renal Cell Carcinoma | 1.28e-03 | 128 | 274 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.28e-03 | 128 | 274 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.28e-03 | 128 | 274 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.28e-03 | 128 | 274 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.28e-03 | 128 | 274 | 6 | C1306837 | |
| Disease | Sjogren's syndrome (is_marker_for) | 1.39e-03 | 24 | 274 | 3 | DOID:12894 (is_marker_for) | |
| Disease | urinary albumin to creatinine ratio | 1.48e-03 | 179 | 274 | 7 | EFO_0007778 | |
| Disease | ovarian neoplasm | 1.62e-03 | 134 | 274 | 6 | C0919267 | |
| Disease | 1-palmitoyl-GPE (16:0) measurement | 1.75e-03 | 7 | 274 | 2 | EFO_0800245 | |
| Disease | obsolete_interleukin-1 alpha measurement | 1.75e-03 | 7 | 274 | 2 | EFO_0802653 | |
| Disease | Usher Syndrome, Type III | 1.75e-03 | 7 | 274 | 2 | C1568248 | |
| Disease | birth measurement, spontaneous preterm birth | 1.75e-03 | 7 | 274 | 2 | EFO_0006917, EFO_0006921 | |
| Disease | lithostathine-1-alpha measurement | 1.75e-03 | 7 | 274 | 2 | EFO_0801083 | |
| Disease | Usher syndrome | 1.75e-03 | 7 | 274 | 2 | cv:C0271097 | |
| Disease | Malignant neoplasm of ovary | 1.81e-03 | 137 | 274 | 6 | C1140680 | |
| Disease | uric acid measurement | ZNF318 ADGRV1 HFM1 BICC1 GAREM1 WDR72 DNAH3 FAT4 FRAS1 CARMIL1 TTC27 CUBN MAP4K5 ATP2A2 | 1.84e-03 | 610 | 274 | 14 | EFO_0004761 |
| Disease | urate measurement, bone density | ABCA8 DOCK5 SLC26A8 PTPRG MIPEP DNAH8 FRAS1 SYNE1 CARMIL1 AHCTF1 DNAH1 MAP4K5 USP40 DNAH11 | 2.10e-03 | 619 | 274 | 14 | EFO_0003923, EFO_0004531 |
| Disease | C-reactive protein measurement | VPS13C ENTR1 TLR8 HSPA12A TBC1D1 PCDH15 HFM1 SNX11 MS4A6A RAB26 WDR72 NPC1 CAD DDX52 CARMIL1 CEP192 MAP4K5 RORA MAPK6 IL6 TP53BP1 DNAH11 | 2.12e-03 | 1206 | 274 | 22 | EFO_0004458 |
| Disease | Congenital disorder of glycosylation type 1q | 2.32e-03 | 8 | 274 | 2 | C4317224 | |
| Disease | female breast cancer (is_implicated_in) | 2.32e-03 | 8 | 274 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Hereditary spherocytosis | 2.32e-03 | 8 | 274 | 2 | C0037889 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.32e-03 | 8 | 274 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Hodgkin's lymphoma (is_marker_for) | 2.32e-03 | 8 | 274 | 2 | DOID:8567 (is_marker_for) | |
| Disease | free cholesterol in very large VLDL measurement | 2.51e-03 | 61 | 274 | 4 | EFO_0022274 | |
| Disease | uterine fibroid | 2.68e-03 | 199 | 274 | 7 | EFO_0000731 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.82e-03 | 63 | 274 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | total cholesterol measurement, C-reactive protein measurement | 2.94e-03 | 31 | 274 | 3 | EFO_0004458, EFO_0004574 | |
| Disease | Adult Hepatocellular Carcinoma | 2.96e-03 | 9 | 274 | 2 | C0279607 | |
| Disease | Autistic Disorder | 3.19e-03 | 261 | 274 | 8 | C0004352 | |
| Disease | severe acute respiratory syndrome, COVID-19 | SPEF2 SLFN5 LYST MAGI2 HSPA12A NRXN1 MYO3B SIPA1L2 SLC25A17 TRPC7 UNC13C | 3.28e-03 | 447 | 274 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 3.41e-03 | 108 | 274 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | Non-Small Cell Lung Carcinoma | 3.46e-03 | 156 | 274 | 6 | C0007131 | |
| Disease | DNA methylation | GALK2 ABCA13 TMEM135 MC5R CDK14 SGCZ MDN1 NRXN1 MYO3B MIPEP FAT4 NLRP1 MAP4K5 DNAH11 | 3.53e-03 | 656 | 274 | 14 | GO_0006306 |
| Disease | HOYERAAL-HREIDARSSON SYNDROME | 3.68e-03 | 10 | 274 | 2 | C1846142 | |
| Disease | response to carboplatin, response to antineoplastic agent | 3.68e-03 | 10 | 274 | 2 | GO_0097327, GO_0097328 | |
| Disease | transverse temporal cortex volume measurement | 3.68e-03 | 10 | 274 | 2 | EFO_0010336 | |
| Disease | Congenital Disorders of Glycosylation | 3.68e-03 | 10 | 274 | 2 | C0282577 | |
| Disease | free cholesterol in large VLDL measurement | 3.72e-03 | 68 | 274 | 4 | EFO_0022265 | |
| Disease | Disorder of eye | 3.80e-03 | 212 | 274 | 7 | C0015397 | |
| Disease | chronic rhinosinusitis | 3.83e-03 | 34 | 274 | 3 | EFO_1000024 | |
| Disease | Schizophrenia | DGCR6 ABCA13 MC5R CFAP65 MAGI2 SLC26A8 HSPA12A SERPINI1 NRXN1 PIK3CA ADGRF4 KIF2A DNMT3B PAH MTR ATP2A2 IL6 | 3.92e-03 | 883 | 274 | 17 | C0036341 |
| Disease | susceptibility to mononucleosis measurement | 3.92e-03 | 69 | 274 | 4 | EFO_0008403 | |
| Disease | breast size | 3.92e-03 | 69 | 274 | 4 | EFO_0004884 | |
| Disease | Mammary Carcinoma, Human | ZEB2 NDRG1 PIK3CA MACIR DNMT3B RAD51C SYNE1 CCNE1 MTR NCOA1 IL6 TP53BP1 | 3.93e-03 | 525 | 274 | 12 | C4704874 |
| Disease | Mammary Neoplasms, Human | ZEB2 NDRG1 PIK3CA MACIR DNMT3B RAD51C SYNE1 CCNE1 MTR NCOA1 IL6 TP53BP1 | 3.93e-03 | 525 | 274 | 12 | C1257931 |
| Disease | Mammary Neoplasms | ZEB2 NDRG1 PIK3CA MACIR DNMT3B RAD51C SYNE1 CCNE1 MTR NCOA1 IL6 TP53BP1 | 4.05e-03 | 527 | 274 | 12 | C1458155 |
| Disease | coronary artery disease | ANKRD31 ABCA8 ZEB2 DOCK5 IFIH1 SGCZ NRXN1 SHOC1 DENND5A BICC1 WDR72 NPC1 EXOC6 FAT4 CARMIL1 RNF213 DCLRE1B EPG5 SF3B3 TMEM132D ICA1L | 4.05e-03 | 1194 | 274 | 21 | EFO_0001645 |
| Disease | Kartagener Syndrome | 4.16e-03 | 35 | 274 | 3 | C0022521 | |
| Disease | Inflammatory Bowel Diseases | 4.16e-03 | 35 | 274 | 3 | C0021390 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 4.16e-03 | 35 | 274 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 4.16e-03 | 35 | 274 | 3 | C4317124 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 4.47e-03 | 11 | 274 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | smoking status measurement, forced expiratory volume | 4.47e-03 | 11 | 274 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | follistatin measurement | 4.47e-03 | 11 | 274 | 2 | EFO_0010614 | |
| Disease | spontaneous preterm birth, parental genotype effect measurement | 4.47e-03 | 11 | 274 | 2 | EFO_0005939, EFO_0006917 | |
| Disease | Breast Carcinoma | ZEB2 NDRG1 PIK3CA MACIR DNMT3B RAD51C SYNE1 CCNE1 MTR NCOA1 IL6 TP53BP1 | 4.77e-03 | 538 | 274 | 12 | C0678222 |
| Disease | nucleotide measurement | 4.79e-03 | 73 | 274 | 4 | EFO_0010513 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 4.87e-03 | 37 | 274 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 5.26e-03 | 38 | 274 | 3 | DOID:114 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 32:1 measurement | 5.26e-03 | 38 | 274 | 3 | EFO_0010373 | |
| Disease | response to risperidone | 5.26e-03 | 38 | 274 | 3 | GO_0097336 | |
| Disease | behavioural disinhibition measurement | 5.28e-03 | 75 | 274 | 4 | EFO_0006946 | |
| Disease | Bipolar Disorder | ABCA13 MAGI2 ADRB2 NRXN1 DNAH8 TRPC7 SYNE1 MTR RORA MBD5 IL6 | 5.31e-03 | 477 | 274 | 11 | C0005586 |
| Disease | 3-aminoisobutyrate measurement | 5.33e-03 | 12 | 274 | 2 | EFO_0010980 | |
| Disease | phosphatidylcholine 34:4 measurement | 5.33e-03 | 12 | 274 | 2 | EFO_0010378 | |
| Disease | bone quantitative ultrasound measurement | 5.65e-03 | 39 | 274 | 3 | EFO_0004514 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLEAILGKETEVSSN | 1116 | P23470 | |
| LFIEGLSSTDAEQLK | 81 | Q9BXU7 | |
| LSEDGEITDFQLLKV | 561 | Q9BXU7 | |
| QLEKNVEDFLALTGI | 546 | Q15361 | |
| LILTAKIGFSAADAV | 316 | O00400 | |
| TLGQTELQLKEFLSI | 256 | Q719I0 | |
| LKVIFLVNSGSEANE | 161 | Q9BYV1 | |
| VLSEKQSGDVELVLA | 31 | Q96EY9 | |
| VEQELLFVGSETGKL | 386 | Q9Y2R4 | |
| SANLEKIITIGLFFS | 536 | P16452 | |
| FANSLVELLAVGLET | 616 | Q9HCE0 | |
| SSFLKELLVEIGESL | 306 | O95394 | |
| AIVFGNVLVITAIAK | 46 | P07550 | |
| AIISISDGLNLVAEK | 106 | Q96JP9 | |
| EVSADKLVALGLFSQ | 271 | Q9UBC3 | |
| IGKLLLAAEVFSETS | 331 | A4D0V7 | |
| ETLTLFLIKNIGLSD | 161 | P78363 | |
| KTIQNLATFVELLGL | 41 | P22760 | |
| DILLQLGIEEAFTSK | 326 | P01011 | |
| VELQIGDAAFSLTKL | 56 | Q504U0 | |
| SVSGESLDLLKVFLN | 376 | Q9BX10 | |
| TFFESIKEILLRQSG | 3781 | Q6V0I7 | |
| TSGNIAFIVELLKNI | 156 | Q8IZF3 | |
| AFIVELLKNISTDLS | 161 | Q8IZF3 | |
| IFLIQLKSVEGGAEI | 231 | Q8WXG9 | |
| IGISSLFIAAKLEEI | 191 | P24864 | |
| QLIGITSLFIASKLE | 186 | O96020 | |
| LLLTFGAKANVLTEE | 161 | Q96NS5 | |
| QFKGSTLALVIITLE | 301 | Q6ZMN8 | |
| VATFILQKILLDDTG | 181 | Q92600 | |
| AIGVKFLINEATTLA | 1416 | Q96DT5 | |
| SFLVLINDLLASGEI | 2921 | Q96DT5 | |
| TLTGLKQLLIIDEDF | 1061 | Q86UQ4 | |
| IDTILVKGNIAATVF | 496 | Q13489 | |
| STLVADLQLIDFEGK | 81 | Q9Y376 | |
| FDLKFLTNGSVSVVL | 296 | O94923 | |
| SVQKLNEFLLSDEIG | 601 | O60706 | |
| ILKAALAETDGEFSL | 126 | O60306 | |
| NLLISDTGELKLADF | 261 | O94921 | |
| LALALLDGTVFEIVQ | 51 | Q14129 | |
| ETAVKFATQLIDLGA | 126 | Q8N3C7 | |
| TLTDQDLKELGITTF | 906 | Q9H694 | |
| VQLLGLADVFTVEEK | 211 | Q9H816 | |
| SKVVLLEDLASQVGL | 226 | Q96HY6 | |
| FGEQLSKVISLICVA | 256 | O14983 | |
| GLIITGKTLEFALQE | 996 | Q9P241 | |
| KLVSAGFQTAEELLE | 26 | O43502 | |
| GLNVDLAFTAIAKEL | 211 | Q9ULW5 | |
| NAILDLSVFGKEVTL | 111 | Q6ZSC3 | |
| AGTLEKLVENLLTAF | 71 | Q9NZL6 | |
| ELLKDVLSVESAGTL | 86 | Q86YS3 | |
| SDAFQKLLIVVLESG | 211 | Q8NG50 | |
| QLAAELAEFTAKIAL | 416 | P35241 | |
| TRQVLGKEDLTAFSL | 561 | O75106 | |
| SNEGSIDIIVELLKA | 1196 | Q8N7Z5 | |
| ILVGSLEKNEFITLA | 401 | Q9NRJ5 | |
| DFNSKEALLLVTVLT | 976 | Q9NVI1 | |
| RLAIGFSTVQKEAVL | 116 | P58400 | |
| NQTILKEFILVGFSV | 21 | Q8NGY0 | |
| ALQQETVIKFGELLS | 726 | Q96AA8 | |
| AKLLSVLAQVFTELA | 4636 | Q9NU22 | |
| ALLGEFTQAKVIIND | 2651 | Q86XX4 | |
| SGSKLVSEELLLEVN | 56 | Q86UL8 | |
| SVALILIFDSGVDLN | 486 | Q9UPQ8 | |
| QVFVEEVLKIALSDG | 221 | Q4G0X4 | |
| LEFQEGDIILVLSKV | 476 | P19878 | |
| DNLGTTIKLVIFNEL | 436 | Q8N201 | |
| ELQSKVEFLLLEGAT | 476 | Q8IX03 | |
| SIAVKALQIDSFGLV | 711 | Q9NVR5 | |
| KDSQALSLGEEVFLL | 2981 | Q8NDA2 | |
| VVFLALKNSGVVSLD | 1186 | Q6ZU64 | |
| ASETALLKFSEVILG | 466 | P54707 | |
| KVAIITDINLFLGEA | 1831 | O43451 | |
| LSGQLELKSVILEAF | 851 | Q86VP6 | |
| SNKSEGLAVLAVLIE | 161 | O43570 | |
| AKQIELQFTIGEAIT | 891 | Q5VYK3 | |
| LKDVTELQILGEISF | 1081 | P38570 | |
| LSGLFLNEEVLSLKV | 361 | Q6PEV8 | |
| SQVKLGSAADFLLDI | 1916 | O75369 | |
| EGKVLFNNTLSFIVI | 276 | P50135 | |
| SSLDVFIIGAVAKAI | 201 | O43808 | |
| LVGFTTGEELLKLAQ | 61 | Q96GV9 | |
| ANLFINTEDLVLKIG | 156 | Q16659 | |
| TLDASDDGILAKIVV | 101 | O00330 | |
| KITVLIDNNDVSIFG | 531 | Q7Z5P9 | |
| AINTSLFVLGKVVDA | 296 | Q14807 | |
| ELAQSKVVSLAELIG | 371 | Q9C000 | |
| LVEKGETITGLLQEF | 16 | Q92597 | |
| FESNIGDLASILKVE | 491 | Q12996 | |
| LNDLKAVSVESLLAF | 1476 | Q14999 | |
| SLNKFLAVLESEIAV | 421 | Q8IXT1 | |
| QEEALFTVLDASKGL | 36 | Q96JB1 | |
| SFFVTEKIDGNLLVQ | 831 | Q9H706 | |
| AELTIEILSDAGVKA | 1186 | Q14315 | |
| QSISFLAEEGTAKLI | 191 | Q01415 | |
| VKEGTQEEAASTLLL | 326 | Q8N2G8 | |
| LSGLFVISKDLFLES | 136 | Q96PG2 | |
| AGDLSKETDLILTFN | 86 | Q5VXU1 | |
| FVKDLILLVNDTAAV | 301 | O60662 | |
| ADFSLLDGIKANVIL | 276 | P16050 | |
| AVELSALLAQTKFGD | 116 | Q8WY64 | |
| VEILTVALDGSLALF | 101 | Q9BY08 | |
| SDGFIIVADQSVILL | 56 | P50748 | |
| DIVLAKVISLGDAQS | 126 | Q9Y3B2 | |
| QVSLQDLEKLSGLVF | 266 | Q9Y2C4 | |
| ELIAIISSDGLNVEK | 176 | Q2TBA0 | |
| FISADQSVALGELVK | 571 | O43301 | |
| SLFAVAKLLETGLVN | 791 | Q7Z3U7 | |
| RLAIGFSTVQKEAVL | 1151 | Q9ULB1 | |
| IDQAGLFLTAIEISL | 106 | Q9Y2J8 | |
| LGFEKDITVILNAVN | 396 | Q9H8H2 | |
| ETLCQTKVLLDIFTG | 926 | P49916 | |
| GVLADVILLKENSTA | 451 | Q8IWF2 | |
| LFIGANESVSLKLTE | 396 | P34949 | |
| ELKNLTVIFADTLQG | 391 | Q8TAG9 | |
| EVSLTLTNKFEGLEA | 1341 | Q86VI3 | |
| QNGAISLIFSLKEEV | 31 | P00439 | |
| LTQDFLIVISKGAQE | 956 | P42336 | |
| EKVQIAAIVLGSLFL | 181 | Q86YJ5 | |
| VFLLESAKDLDVGIN | 151 | Q9Y5F1 | |
| SKDALFETLIQLGVL | 351 | Q6ZMV5 | |
| TIEGFLQALSLAVDK | 406 | Q15645 | |
| VFLLESAKDLDVGIN | 151 | Q9Y5F2 | |
| LISSEFVGLDIQQKL | 1076 | A2PYH4 | |
| TQKFINAEELVGLLD | 151 | Q96MD2 | |
| IFVGVLSFSIAVLNK | 841 | O15118 | |
| LSFSIAVLNKVDIGL | 846 | O15118 | |
| SLAEVGTEEFLQKLT | 5526 | Q5VST9 | |
| ADLLVSSAFIKAQEL | 581 | Q9QC07 | |
| ASKLTQVLRDSFIGE | 506 | O00139 | |
| TTILQIEAKDVDLGA | 836 | Q96QU1 | |
| NLVTEVLGALEAKTG | 16 | Q96HR9 | |
| SLLTLLIFAEVNGEA | 11 | O60494 | |
| EKLEGLQLVVAGFSI | 951 | Q9P2D7 | |
| ILEKLLDNGATVDFQ | 196 | Q9GZV1 | |
| FGEQLSKVISLICIA | 256 | P16615 | |
| EEIGDKVLVFSQSLI | 2031 | P46100 | |
| TLETLKNIGCFLLEV | 576 | Q7Z4Q2 | |
| IFTAVLSALKGLAEN | 826 | Q9P2D3 | |
| LFLDIILKTVLENSG | 481 | Q9NPB8 | |
| ALVFIISLIGDIKFQ | 696 | Q9H7D0 | |
| VGEDFNIKVIFSTLL | 111 | Q8N0S6 | |
| TLELKSINGEECFLL | 826 | Q9H799 | |
| GNILEDETAIKVLSS | 3251 | Q8TD57 | |
| LTGDLAVLKDQVFVL | 111 | Q99819 | |
| LNLVLGVLSGEFTKE | 326 | Q13698 | |
| IFLKEQTLQAGILEV | 2301 | Q8TD26 | |
| VSGAETLNLVAEILK | 406 | Q96C92 | |
| LGINLATADTVIIFD | 1141 | Q12873 | |
| SKENLIFSVGELIIA | 296 | Q6VVX0 | |
| IILVDDFSSNGELKV | 216 | Q9NY28 | |
| GEKNVFEALSELIIL | 196 | Q16850 | |
| SITDLGFCNVILVKE | 66 | Q6NUI2 | |
| GKINLLIATTVAEEG | 781 | Q9BYX4 | |
| SDVLLKLVLEQGDSS | 2281 | Q5VT06 | |
| GIFETLIKDTIDVLN | 3091 | Q5VT06 | |
| GSSELEKVGSIFLQL | 146 | Q86VX2 | |
| LALALLDGTVFEIVQ | 51 | Q9BY27 | |
| QEFNITLETSLVKGI | 1271 | Q6IQ26 | |
| AKLDLTVNFIGELSS | 91 | Q86X45 | |
| SLKAFETLIISLGEQ | 816 | Q99698 | |
| LSALVGFIILSVKQA | 126 | Q9H2W1 | |
| IKAEVGDTLLVTFAN | 461 | Q6MZM0 | |
| EVFLTLGVISLLENI | 41 | P33032 | |
| FGELLSTAKQDLVLE | 1301 | Q9P267 | |
| IKGATIVDALDTLFI | 236 | P33908 | |
| TLKGFDQTINLILDE | 26 | O95777 | |
| FEALLVIQTDEGKSI | 2511 | Q8TEP8 | |
| GDDVSFLVNSLKLDL | 451 | Q92636 | |
| TFVKNVLLEQSGIDI | 816 | Q5VZK9 | |
| TERGLIDLSNKFVVS | 646 | Q8WYP5 | |
| QVVLDKGTLDAVLTD | 116 | Q8N6R0 | |
| GFLTEQLNKLVLSDE | 281 | Q8NDH6 | |
| VRTLFLLGTASKQEE | 171 | Q8NFL0 | |
| QTILFSLTDLEKGIQ | 4201 | Q9P225 | |
| TAFQEQEIDGKSLLL | 481 | Q6SPF0 | |
| SQDGRLVKSSILVFD | 3911 | Q9NZJ4 | |
| EGLKLQALFTAVLLS | 326 | O00411 | |
| CEILSSLQIGDFLVK | 196 | P12081 | |
| AQLSATIFRKEGLEA | 101 | Q8TEX9 | |
| LFEDTVLITGKLADA | 176 | Q6P995 | |
| FNEETCLVKIITGLL | 106 | P05231 | |
| LTELGFLTKLQELSI | 201 | Q05469 | |
| LADFGVAAKITATIA | 156 | Q9Y4K4 | |
| AAEKNFLTTVAILLE | 641 | Q99549 | |
| VQSFLASLDGEKLEL | 316 | Q8IWE2 | |
| LVSAQKVLEGSELEL | 81 | Q14980 | |
| LTQAEGAFVASLIKE | 76 | P05451 | |
| LTQAEGAFVASLIKE | 76 | P48304 | |
| GITEIFIKDANLTGL | 311 | Q99574 | |
| ATGLEASKVEVLLLE | 696 | A6NES4 | |
| TSLQAELEKGSLFLV | 276 | O15296 | |
| KELLSAEAVSEFIGL | 1311 | Q5JY77 | |
| TAGLQKLADIIQIVF | 386 | Q9NZ71 | |
| DSKGLDTVVALLADV | 156 | Q10713 | |
| FLLDGKVLSLTDFQT | 316 | Q8N1F8 | |
| LDLGLFSTKTLVEAN | 926 | O14607 | |
| LVGLSDELAKLDAFV | 51 | P21283 | |
| GNKAFTDILIDLVTL | 1486 | Q9C093 | |
| EAEGLKFSLSLENVL | 376 | Q92673 | |
| FLEKVLQSVVLLSDS | 106 | Q9Y5W9 | |
| QLLAKTIEGITLEEF | 51 | O14717 | |
| NAAFKDVALVLTVLL | 386 | Q8NFQ8 | |
| EINLNIKVTDFGLAV | 256 | Q9BYT3 | |
| TFKAVLDGLDVLLAQ | 96 | P78395 | |
| QKDELSFSEGEIIIL | 586 | Q5HYK7 | |
| VKSLQALGEVIEAEL | 41 | Q9Y285 | |
| FLVQTEQKLAVEISG | 7471 | Q8NF91 | |
| VLISLAALFSKVTEG | 16 | Q14C87 | |
| FALILEQLTAIEGAV | 391 | Q5TCX8 | |
| TKQDFVTILDVNLLG | 126 | O75452 | |
| VRQLLKTELGSFFTE | 71 | P85299 | |
| ELFLIIGFTVIANKI | 311 | Q96RN1 | |
| ALLEQLVSFLSGKDE | 931 | Q15788 | |
| VDSILQTDDATLGKL | 161 | P78549 | |
| QTAISKFLLLGLIED | 6 | Q8NG99 | |
| LEKVAATLQTLFLVD | 346 | A3QJZ6 | |
| KVDIEVLSVLASLGA | 246 | P30566 | |
| LILLEAQAATGFIID | 641 | P58107 | |
| LLIETIFDTANAKAA | 191 | Q99707 | |
| AGLINIVSFDLLSKL | 521 | Q9NZC9 | |
| ATLESVFQELGKLTG | 196 | P13521 | |
| VSEQLLKLDEQGLSF | 591 | Q9P2F8 | |
| SFGLNSEELDVKLII | 986 | Q5VXU9 | |
| DVLLGNSVNFTVILK | 481 | P49221 | |
| STEGEIFLNAETIKL | 231 | Q96LD1 | |
| TFTVGLVFLKTDNLE | 321 | Q5PT55 | |
| TEVTLFVLKGFTDNL | 46 | Q8NGG2 | |
| FVLKGFTDNLELQTI | 51 | Q8NGG2 | |
| VDLAFSTLVQLIDKS | 236 | Q9NRY4 | |
| NKEFGDSLSLEILQI | 51 | Q9UHB9 | |
| GLAVVDFIQKTVLLS | 661 | Q9Y2K9 | |
| FTEKGNLEVLLFTIQ | 356 | Q01082 | |
| AQFKGTQSLLLEVDA | 836 | Q9UK61 | |
| LIINKTGASIDDFIQ | 916 | O94911 | |
| GDQLLSTTVFFENIK | 156 | Q8IVF2 | |
| NVLLKSDLTAVLADF | 326 | Q13705 | |
| KVLIVLNGAFSSIEE | 136 | O43529 | |
| SNLDTLVSIGLDEKF | 791 | Q15021 | |
| QFIEKDLILLGATAV | 666 | Q9Y2G3 | |
| SVIVKTQEGDILLFC | 551 | Q8NB49 | |
| VDLTITNLLEGAVAF | 326 | Q9Y679 | |
| QGTTFLGSLIFEKEI | 161 | Q9BXU1 | |
| LKVFVDLASISAGEN | 1441 | Q63HN8 | |
| ESKSLVELVFSGNRL | 606 | Q9NR97 | |
| NITTDKILIDVFDGL | 456 | P56180 | |
| AFLLSGVLLSEAAKI | 11 | Q6NUS8 | |
| SLFVEKSSLAAVQEL | 91 | Q9ULJ3 | |
| FALVGLAKLSEEISA | 16 | Q8NCS4 | |
| IGATLTDVQDVVFKL | 2811 | Q96RL7 | |
| AAFKDVALVLTVLLE | 501 | Q5JTV8 | |
| IFKELQGISQIETEL | 246 | Q8NB66 | |
| VDLNVKILDLSSTFL | 206 | Q99797 | |
| LLDFQVVVLTAAKLE | 116 | P41226 | |
| DQIVLLKAGSLEVVF | 351 | P35398 | |
| SFTFLEDLQAKILGI | 221 | Q9UIV8 | |
| KSSGVFLQLQLEEES | 231 | Q8N1Q8 | |
| ELLITNKGSELAFAD | 1166 | Q15413 | |
| FSNVQFILKASEIIG | 216 | C9JQI7 | |
| SVLECLDSVGQKLLF | 421 | Q96IC2 | |
| AVSVAGSILAKALLE | 426 | Q96MS0 | |
| LAGESVEFQNLATLK | 896 | P24928 | |
| LQFALGEVEVLSKQL | 81 | Q86W54 | |
| FLQGTEVIFKVALSL | 991 | Q86TI0 | |
| KALLEQGFTDVTVLE | 41 | Q9NWM0 | |
| QEDSLLVVSVAGELK | 171 | Q3MJ13 | |
| SFLQITGGALEESLK | 26 | Q86UB9 | |
| SLQKLFQIEESSGIL | 401 | A0A1W2PR48 | |
| LSSTENLKGFIEIII | 311 | Q9NXF1 | |
| DNELTFKAGEIITVL | 226 | Q92783 | |
| VLLFTDDVALVSKAL | 3061 | Q709C8 | |
| LTKAADISLDNLVEG | 1611 | Q12888 | |
| FLAQTEQGDIFKITL | 301 | Q15393 | |
| GLAAVQKFTILIDVT | 296 | Q8NB14 | |
| FSDKQIALAVLSTEL | 871 | P27708 | |
| VFLGIAVSKQDLITC | 41 | Q8TD23 | |
| VAEVKSFLIQLEAFL | 146 | Q5T4F4 | |
| IQELLLGKEFLNITT | 581 | Q08ER8 | |
| SDAVLELFKLTIGLG | 626 | Q8NET8 | |
| GVFVDNKALLLSSVL | 626 | O60315 | |
| SEVKGLDAFVLSLLT | 131 | Q6P3X3 | |
| LDLTVAVKNVSGLED | 186 | Q9NVE5 | |
| DILLTFTQGVNEKLT | 1066 | Q69YN4 | |
| SELDKVAQILGINIF | 971 | Q5VUA4 | |
| KSFLSEELGSEVLNL | 541 | Q08AF3 | |
| AIIFTLIVGKALGED | 91 | Q8WY98 | |
| LLLAIKTANFVAVDT | 51 | Q96GM8 | |
| GLSSEFLLVLVNLVK | 171 | P49815 | |
| FQDLVDSLSDGKIAL | 701 | Q9P1Q0 | |
| TGELADLIQQLSEKF | 831 | Q9HCX4 | |
| SLLSGKEEAIQVAIA | 2386 | Q14789 | |
| VQLISELAAKESLIF | 746 | Q9C099 | |
| NILLTTEGGVKLVDF | 161 | Q8WXR4 | |
| SSLVLIGDAFKTVLE | 1101 | P54296 |